data_2pku_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pku _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.587 0.232 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' B' ' 125' ' ' ILE . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.654 0.264 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CE1' ' CG ' ' B' ' 124' ' ' LYS . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.572 0.225 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.334 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.563 0.22 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.654 0.264 . . . . 0.0 110.758 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 65' ' ' ALA . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CE2' ' HD2' ' B' ' 124' ' ' LYS . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD2' ' CD2' ' A' ' 101' ' ' TYR . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 68' ' ' ASP . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.625 0.25 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.738 0.304 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 70' ' ' ILE . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.66 0.266 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.697 0.284 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 7.7 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 4.4 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.401 ' CD1' ' O ' ' A' ' 47' ' ' LEU . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . 0.416 HD13 ' CG2' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.686 0.279 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.815 0.341 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.419 ' CG2' HD13 ' B' ' 125' ' ' ILE . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 70' ' ' ILE . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . 0.419 HD13 ' CG2' ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.663 0.268 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.748 0.309 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 mp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.323 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.591 0.234 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CE1' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.415 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.411 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' B' ' 125' ' ' ILE . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 100' ' ' HIS . 5.1 m-70 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.58 0.229 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 70' ' ' ILE . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.663 0.268 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.744 0.307 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 93' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.62 0.248 . . . . 0.0 110.939 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.81 0.338 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 63' ' ' THR . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.681 0.276 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CG2' ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.84 0.353 . . . . 0.0 110.804 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.741 0.305 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 52' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.414 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . 0.421 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.708 0.289 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' B' ' 124' ' ' LYS . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.2 p30 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.733 0.301 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 33' ' ' ILE . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.785 0.326 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.0 t . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.467 0.175 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.744 0.307 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 49' ' ' ILE . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.32 114.31 33.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.0 170.05 42.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.58 -139.47 4.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.7 149.81 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.107 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.08 25.25 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.17 -46.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.59 60.61 45.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.94 -7.14 20.51 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.637 2.224 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.31 100.73 5.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -83.62 135.31 34.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.822 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.424 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.403 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' B' ' 125' ' ' ILE . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.424 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.848 0.356 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.0 90.99 50.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' O ' ' CG2' ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.421 ' CG2' ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -166.6 170.0 40.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.24 -138.09 3.3 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.605 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.24 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 65.85 -76.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.56 -35.78 77.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.45 64.89 11.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 -40.74 62.96 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.227 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -61.64 133.59 55.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -96.86 131.52 43.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' CE1' ' CG ' ' B' ' 124' ' ' LYS . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.905 0.384 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 9.6 p -121.87 107.74 35.46 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.86 165.22 50.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.25 93.91 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.63 -54.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.369 . . . . 0.0 111.112 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.94 -55.63 2.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.816 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.19 29.22 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.776 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.44 127.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 -11.76 26.14 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.343 2.029 . . . . 0.0 112.902 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.8 p -155.54 164.75 38.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.934 0.397 . . . . 0.0 111.125 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 tp -69.96 170.07 12.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.789 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 4.9 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.911 0.386 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.67 97.45 50.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -162.13 156.8 28.5 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -169.95 88.82 0.09 OUTLIER Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.408 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.04 -29.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.24 -32.56 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.21 29.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.63 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER 172.56 75.11 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.483 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 -14.32 44.07 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.457 2.104 . . . . 0.0 112.591 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 7.6 m -82.64 135.4 35.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.59 151.12 21.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.403 ' CG2' ' HA ' ' A' ' 65' ' ' ALA . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.412 ' CE2' ' HD2' ' B' ' 124' ' ' LYS . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.403 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.403 ' OD2' ' CD2' ' A' ' 101' ' ' TYR . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.403 ' CD2' ' OD2' ' A' ' 68' ' ' ASP . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.684 0.278 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.1 81.06 15.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.414 ' CD1' HG12 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.414 HG12 ' CD1' ' A' ' 33' ' ' ILE . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.79 167.85 40.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.59 -130.86 4.59 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -175.8 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.13 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.24 -30.32 60.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -115.46 -38.91 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.06 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.64 87.54 45.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 -27.6 20.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.601 2.2 . . . . 0.0 112.309 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 t -68.71 134.36 49.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.17 135.39 45.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.485 HD12 HG23 ' A' ' 70' ' ' ILE . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.92 95.0 5.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.06 165.34 38.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.15 -124.58 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.577 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -160.76 -64.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -90.67 -61.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -68.42 -47.74 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.035 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 m -120.64 75.91 26.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 -11.69 26.47 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 0.0 112.604 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.1 147.77 32.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.872 0.367 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -115.48 154.42 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.719 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.338 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 7.7 p -120.98 94.34 48.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.07 145.79 9.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.95 -121.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.518 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -168.86 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 111.198 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -85.55 -52.66 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.57 19.45 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.94 64.27 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 -9.1 23.42 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.561 2.174 . . . . 0.0 112.602 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 67.2 m -69.35 127.99 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.816 0.341 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 48' ' ' TYR . 4.4 mm? -110.85 144.21 40.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CZ ' ' HB3' ' A' ' 46' ' ' CYS . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CG2' HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.402 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . 0.416 HD13 ' CG2' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 73.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.8 91.42 48.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.05 145.4 9.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.31 4.06 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.84 -76.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -76.29 -35.76 58.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -91.36 -31.13 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.4 m -151.91 79.86 6.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -23.3 42.76 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.41 128.8 37.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.993 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -101.5 148.78 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.71 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.417 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.417 ' HG3' ' CZ ' ' A' ' 48' ' ' TYR . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.419 ' CG2' HD13 ' B' ' 125' ' ' ILE . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.412 ' CG2' ' CD1' ' A' ' 70' ' ' ILE . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . 0.419 HD13 ' CG2' ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.3 p -136.22 97.84 11.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.76 169.58 42.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.22 -130.02 6.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.77 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -73.79 -45.7 49.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -114.77 -37.8 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.86 78.69 5.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.85 -42.04 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.9 m -63.22 107.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.65 137.65 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 3.8 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.98 100.29 11.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.96 168.68 41.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.41 -124.66 5.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.563 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -175.37 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.036 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -103.39 -47.2 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.33 -30.67 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.66 64.19 56.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.1 -28.63 70.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.531 2.154 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.16 132.69 37.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.9 mp -99.74 169.92 8.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.794 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.406 HG13 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.416 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.416 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.406 ' CD2' HG13 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 68.1 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.89 94.79 45.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.22 41.21 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.34 -135.9 4.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -159.31 -48.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.109 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -53.75 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -83.22 -30.5 27.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -135.39 64.43 59.25 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.74 -34.11 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.622 2.214 . . . . 0.0 112.22 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 2.0 m -60.01 152.26 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.761 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.421 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.411 HG22 ' CE1' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.415 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.415 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.411 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.421 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.05 90.64 16.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.32 153.82 25.19 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . -168.89 84.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.416 ' O ' ' CE2' ' A' ' 43' ' ' TYR . . . -58.0 -177.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.188 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 61.54 17.69 8.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.298 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 14.6 p90 172.0 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.619 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.4 m -146.53 75.11 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.18 -23.5 33.37 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.643 2.229 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 31.1 m -57.56 133.08 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -99.74 141.99 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.41 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.412 ' CG2' HD11 ' B' ' 125' ' ' ILE . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' CD2' ' N ' ' A' ' 100' ' ' HIS . 5.1 m-70 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 13.2 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.27 98.7 51.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -158.92 167.47 34.8 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -129.28 -126.65 2.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.503 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.7 158.2 12.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 111.174 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 67.4 -69.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.36 -39.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 56.4 m -125.81 69.33 64.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.97 -30.12 14.2 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.312 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.49 145.04 49.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -117.9 118.55 32.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.475 HG21 HD11 ' A' ' 70' ' ' ILE . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.2 91.24 31.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.06 164.35 37.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.94 -119.73 3.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -175.44 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 111.175 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -81.81 -69.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -71.94 -47.14 54.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.98 74.45 5.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.06 -21.84 36.17 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.48 2.12 . . . . 0.0 112.435 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.64 121.8 11.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.04 127.21 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.413 ' O ' HG12 ' A' ' 93' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.773 0.321 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 12.8 p -106.49 123.57 38.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HE2' ' CG2' ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.65 143.08 7.69 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.6 -128.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -173.31 -41.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -32.61 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.0 -31.73 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.49 64.37 63.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.11 -29.53 66.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.587 2.191 . . . . 0.0 112.243 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 124.46 22.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.2 mp -102.55 138.5 39.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.412 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.426 HG23 ' CE2' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.412 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.407 ' CG2' ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . 0.426 ' CE2' HG23 ' A' ' 63' ' ' THR . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.72 79.1 30.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.417 ' O ' ' CG2' ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.11 156.52 27.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.88 -128.28 4.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.25 147.45 9.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 65.07 -75.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.8 -34.33 52.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.2 60.9 56.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.993 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -7.07 18.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.532 2.154 . . . . 0.0 112.701 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 85.5 m -76.88 127.7 33.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.019 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -108.84 141.72 40.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 99' ' ' ILE . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.409 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.57 90.52 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.421 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.05 169.97 42.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.18 -116.83 1.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.406 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.22 132.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 68.6 -68.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -69.09 -33.98 74.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 69.09 6.8 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.23 -24.55 19.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.36 114.82 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 7.8 mp -102.55 129.09 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.644 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.414 ' HG3' ' N ' ' A' ' 52' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 ' N ' ' HG3' ' A' ' 51' ' ' GLN . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.407 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.408 ' CG1' ' CD1' ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.408 ' CD1' ' CG1' ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . 0.421 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.407 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.32 91.71 17.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.056 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.14 170.06 42.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.7 -124.37 5.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -175.34 -54.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 111.197 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.93 -62.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -79.07 -24.44 43.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.66 74.65 12.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.937 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.3 -26.3 35.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.527 2.151 . . . . 0.0 112.313 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.34 133.9 55.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -97.65 161.92 13.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' CE2' ' HD2' ' B' ' 124' ' ' LYS . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.2 p30 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.38 86.02 55.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.403 HD13 HG23 ' A' ' 33' ' ' ILE . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.1 138.75 5.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -63.57 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.64 -163.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.711 0.291 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 64.37 59.77 0.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.997 0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 29.35 17.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.403 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 68.8 m -150.63 64.58 6.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.403 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 23.6 Cg_exo -64.05 -47.13 6.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.636 2.224 . . . . 0.0 112.088 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.2 169.63 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 6.2 mp -123.47 132.23 53.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.424 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.401 ' CG2' ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.401 ' CD1' ' CG2' ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . 0.424 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.927 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 17.0 t -89.78 106.75 15.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.11 27.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.99 -38.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.652 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . 65.54 160.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 70.04 -64.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.012 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -107.29 -30.73 8.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.107 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 40.9 m -137.17 65.77 51.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.11 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -67.43 -28.27 39.07 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.704 2.27 . . . . 0.0 112.189 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.91 97.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.97 169.98 17.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 HG22 HD11 ' A' ' 49' ' ' ILE . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 125' ' ' ILE . . . . . . . . . . . . . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.587 0.232 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 25' ' ' LEU . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' HD12 ' A' ' 32' ' ' LEU . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 125' ' ' ILE . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 35' ' ' ILE . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 68' ' ' ASP . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG21 ' OG ' ' B' ' 122' ' ' SER . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.5 m120 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.593 ' O ' HD11 ' A' ' 78' ' ' ILE . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' OD1' ' A' ' 102' ' ' ASN . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG11 ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.82 HD22 ' HA ' ' A' ' 97' ' ' VAL . 35.8 m120 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 70' ' ' ILE . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' THR . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.787 ' CD1' HG11 ' A' ' 73' ' ' VAL . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' MET . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.82 ' HA ' HD22 ' A' ' 74' ' ' ASN . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 98' ' ' THR . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 102' ' ' ASN . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 122' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 50' ' ' VAL . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.587 HG23 ' HD2' ' A' ' 83' ' ' LYS . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.607 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.654 0.264 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 63' ' ' THR . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.828 ' HE2' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 125' ' ' ILE . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 35' ' ' ILE . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 39' ' ' GLY . 1.5 mm? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 70' ' ' ILE . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 51' ' ' GLN . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.484 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 52' ' ' VAL . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.616 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 23' ' ' VAL . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' HD11 ' A' ' 49' ' ' ILE . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.828 HG11 ' CD1' ' A' ' 90' ' ' ILE . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 97' ' ' VAL . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' B' ' 123' ' ' VAL . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 82' ' ' THR . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.828 ' CD1' HG11 ' A' ' 73' ' ' VAL . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' MET . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.828 HG21 ' HE2' ' A' ' 27' ' ' LYS . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.578 HD13 HG13 ' A' ' 73' ' ' VAL . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 64' ' ' VAL . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.676 ' O ' HD12 ' A' ' 104' ' ' LEU . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 102' ' ' ASN . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 83' ' ' LYS . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.6 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.572 0.225 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' A' ' 63' ' ' THR . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 96' ' ' GLU . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 58' ' ' ALA . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.746 ' HE2' HG11 ' A' ' 97' ' ' VAL . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 35' ' ' ILE . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 33' ' ' ILE . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 HG21 ' A' ' 86' ' ' VAL . 1.1 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.334 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 68' ' ' ASP . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.604 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.678 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 49' ' ' ILE . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.433 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 86' ' ' VAL . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 86' ' ' VAL . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 85' ' ' GLU . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 84' ' ' VAL . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.863 HG21 HD22 ' A' ' 47' ' ' LEU . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 125' ' ' ILE . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG11 ' HE2' ' A' ' 27' ' ' LYS . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 63' ' ' THR . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.955 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.563 0.22 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.726 ' CG2' HG21 ' A' ' 63' ' ' THR . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 99' ' ' ILE . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.784 ' HD3' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HD3' ' A' ' 27' ' ' LYS . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 33' ' ' ILE . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.654 0.264 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 68' ' ' ASP . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 m120 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 53' ' ' PHE . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.726 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 23' ' ' VAL . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 99' ' ' ILE . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CE ' ' A' ' 89' ' ' MET . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 47' ' ' LEU . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.458 ' CE ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.799 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.536 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 22' ' ' LYS . 4.4 m80 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.625 0.25 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 HG21 ' A' ' 63' ' ' THR . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 63' ' ' THR . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 97' ' ' VAL . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 30' ' ' GLN . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.613 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 49' ' ' ILE . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.738 0.304 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 51' ' ' GLN . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.616 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.671 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' THR . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 m120 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 53' ' ' PHE . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.658 HG21 HG21 ' A' ' 23' ' ' VAL . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 63' ' ' THR . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.725 HG11 HD13 ' A' ' 90' ' ' ILE . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 85' ' ' GLU . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 84' ' ' VAL . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 82' ' ' THR . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.811 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.725 HD13 HG11 ' A' ' 73' ' ' VAL . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' MET . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 27' ' ' LYS . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 104' ' ' LEU . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 103' ' ' LYS . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.66 0.266 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 63' ' ' THR . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 98' ' ' THR . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.866 ' NZ ' HG23 ' A' ' 33' ' ' ILE . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.866 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 HD11 ' B' ' 125' ' ' ILE . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.475 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.697 0.284 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.77 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.705 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 23' ' ' VAL . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 63' ' ' THR . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 52' ' ' VAL . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.77 ' HB2' HD12 ' A' ' 49' ' ' ILE . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 78' ' ' ILE . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG21 ' CD1' ' A' ' 90' ' ' ILE . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.623 ' HE ' HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' B' ' 123' ' ' VAL . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 84' ' ' VAL . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 82' ' ' THR . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' B' ' 125' ' ' ILE . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.758 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.815 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 89' ' ' MET . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HE2' ' A' ' 27' ' ' LYS . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 97' ' ' VAL . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.699 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.7 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 64' ' ' VAL . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 98' ' ' THR . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.815 ' NZ ' HG21 ' A' ' 97' ' ' VAL . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 30' ' ' GLN . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 35' ' ' ILE . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' ILE . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.589 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.4 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.504 ' HA ' HG22 ' A' ' 70' ' ' ILE . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 51' ' ' GLN . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.3 m120 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 53' ' ' PHE . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.714 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.689 HG13 HG11 ' A' ' 23' ' ' VAL . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 48' ' ' TYR . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.536 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 71' ' ' THR . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 86' ' ' VAL . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 82' ' ' THR . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 82' ' ' THR . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.917 HG21 HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' B' ' 125' ' ' ILE . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.47 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.714 ' OH ' HG22 ' A' ' 63' ' ' THR . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.917 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.686 0.279 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.739 ' CG2' HG21 ' A' ' 63' ' ' THR . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 99' ' ' ILE . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HE2' HG22 ' A' ' 90' ' ' ILE . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.804 ' HG3' HD12 ' A' ' 32' ' ' LEU . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.804 HD12 ' HG3' ' A' ' 30' ' ' GLN . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 35' ' ' ILE . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.5 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.815 0.341 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.904 HD12 ' HB2' ' A' ' 68' ' ' ASP . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 56' ' ' THR . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 53' ' ' PHE . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.739 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.904 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 104' ' ' LEU . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.525 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 70' ' ' ILE . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.805 HG11 ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' VAL . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 82' ' ' THR . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.697 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.805 ' CD1' HG11 ' A' ' 73' ' ' VAL . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 89' ' ' MET . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG11 ' HE3' ' A' ' 27' ' ' LYS . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.656 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 25' ' ' LEU . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.663 0.268 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 63' ' ' THR . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD12 HD13 ' A' ' 99' ' ' ILE . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 26' ' ' GLN . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 47' ' ' LEU . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.1 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.748 0.309 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.635 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 53' ' ' PHE . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.691 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 58' ' ' ALA . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 52' ' ' VAL . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB2' HD12 ' A' ' 49' ' ' ILE . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 102' ' ' ASN . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 90' ' ' ILE . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HD3' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.734 ' CD1' HG11 ' A' ' 73' ' ' VAL . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.686 HD13 HD12 ' A' ' 25' ' ' LEU . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.481 HD21 HG21 ' A' ' 71' ' ' THR . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 87' ' ' ALA . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.58 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 97' ' ' VAL . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.767 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 30' ' ' GLN . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 35' ' ' ILE . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 86' ' ' VAL . 8.9 mp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HA ' HG22 ' A' ' 70' ' ' ILE . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 68' ' ' ASP . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.48 ' N ' HG12 ' A' ' 52' ' ' VAL . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 m120 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.758 ' CB ' HD13 ' A' ' 49' ' ' ILE . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.537 HG22 ' HA ' ' A' ' 48' ' ' TYR . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.926 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t30 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 47' ' ' LEU . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.926 ' CD1' HG21 ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG3' HG22 ' B' ' 125' ' ' ILE . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 89' ' ' MET . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 90' ' ' ILE . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 99' ' ' ILE . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 98' ' ' THR . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 122' ' ' SER . . . . . 0.568 ' HB3' HG21 ' A' ' 50' ' ' VAL . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.591 0.234 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' HB ' HG21 ' A' ' 63' ' ' THR . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 97' ' ' VAL . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.4 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' OH ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' B' ' 122' ' ' SER . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.0 m120 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 53' ' ' PHE . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.734 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 49' ' ' ILE . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.528 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 82' ' ' THR . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' B' ' 125' ' ' ILE . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' MET . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 33' ' ' ILE . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 98' ' ' THR . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 122' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.633 HD13 ' HB ' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' CG2' HG21 ' A' ' 63' ' ' THR . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 99' ' ' ILE . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CD1' HD11 ' A' ' 33' ' ' ILE . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 70' ' ' ILE . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.476 ' H ' HG12 ' A' ' 50' ' ' VAL . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 23' ' ' VAL . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 58' ' ' ALA . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 78' ' ' ILE . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 70' ' ' ILE . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 83' ' ' LYS . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 82' ' ' THR . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 87' ' ' ALA . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.852 ' CD1' HG21 ' A' ' 73' ' ' VAL . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' ILE . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG11 ' HE2' ' A' ' 27' ' ' LYS . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 104' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.58 0.229 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 63' ' ' THR . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' GLU . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 23' ' ' VAL . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HD12 ' A' ' 32' ' ' LEU . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 30' ' ' GLN . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 35' ' ' ILE . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.69 HD11 HD11 ' B' ' 125' ' ' ILE . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.8 mm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.516 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.799 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 64' ' ' VAL . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.799 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 23' ' ' VAL . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.595 ' HB2' HD12 ' A' ' 49' ' ' ILE . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.586 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 90' ' ' ILE . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' H ' HG22 ' A' ' 82' ' ' THR . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 82' ' ' THR . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.785 HG21 HD13 ' B' ' 125' ' ' ILE . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 97' ' ' VAL . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 24' ' ' THR . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 93' ' ' VAL . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CD2' HG12 ' A' ' 64' ' ' VAL . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.785 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.663 0.268 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.814 HD12 HD13 ' A' ' 99' ' ' ILE . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 HD11 ' B' ' 125' ' ' ILE . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.744 0.307 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.713 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HB1' ' A' ' 58' ' ' ALA . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 90' ' ' ILE . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t30 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' CE ' ' A' ' 89' ' ' MET . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' H ' HG22 ' A' ' 82' ' ' THR . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 85' ' ' GLU . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 84' ' ' VAL . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 82' ' ' THR . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.429 ' CE ' HG22 ' A' ' 78' ' ' ILE . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.939 HG21 HD13 ' B' ' 125' ' ' ILE . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 97' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 93' ' ' VAL . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.814 HD13 HD12 ' A' ' 25' ' ' LEU . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 22' ' ' LYS . 4.4 m80 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.8 p . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.62 0.248 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 25' ' ' LEU . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 96' ' ' GLU . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HE2' HG21 ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.443 HD21 ' HG2' ' A' ' 91' ' ' GLN . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 35' ' ' ILE . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.479 HD11 HD11 ' B' ' 125' ' ' ILE . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.521 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 86' ' ' VAL . 7.2 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.81 0.338 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 68' ' ' ASP . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.504 HG21 ' CB ' ' B' ' 122' ' ' SER . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.45 ' HG2' HG12 ' A' ' 50' ' ' VAL . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 56' ' ' THR . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' PHE . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.885 ' HB2' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 78' ' ' ILE . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 90' ' ' ILE . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.587 ' OD1' HG21 ' A' ' 93' ' ' VAL . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' HG22 ' A' ' 78' ' ' ILE . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 1.008 HG21 HD13 ' B' ' 125' ' ' ILE . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 32' ' ' LEU . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.587 HG21 ' OD1' ' A' ' 74' ' ' ASN . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HB2' HG22 ' A' ' 24' ' ' THR . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.724 HG21 ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 24' ' ' THR . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 99' ' ' ILE . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 122' ' ' SER . . . . . 0.504 ' CB ' HG21 ' A' ' 50' ' ' VAL . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 1.008 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.681 0.276 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HA ' ' ND2' ' A' ' 102' ' ' ASN . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 96' ' ' GLU . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.837 ' HE2' HG21 ' A' ' 97' ' ' VAL . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.498 ' HB2' HD12 ' A' ' 32' ' ' LEU . 5.4 mm100 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 30' ' ' GLN . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.769 HG23 ' HD3' ' A' ' 27' ' ' LYS . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.84 0.353 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.587 ' HA ' HG22 ' A' ' 70' ' ' ILE . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 51' ' ' GLN . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 50' ' ' VAL . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 53' ' ' PHE . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 53' ' ' PHE . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 48' ' ' TYR . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 86' ' ' VAL . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.85 ' CD1' HG21 ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' MET . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HE2' ' A' ' 27' ' ' LYS . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.561 HD13 HG23 ' A' ' 73' ' ' VAL . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 20' ' ' PRO . 7.1 m120 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.672 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 63' ' ' THR . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 99' ' ' ILE . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 33' ' ' ILE . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 30' ' ' GLN . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 97' ' ' VAL . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 83' ' ' LYS . 7.8 mp . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.741 0.305 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 50' ' ' VAL . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 51' ' ' GLN . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' N ' HG12 ' A' ' 52' ' ' VAL . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m120 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.601 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 101' ' ' TYR . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 48' ' ' TYR . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 86' ' ' VAL . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 47' ' ' LEU . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 47' ' ' LEU . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 89' ' ' MET . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 33' ' ' ILE . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.693 ' C ' HD12 ' A' ' 99' ' ' ILE . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' A' ' 64' ' ' VAL . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 83' ' ' LYS . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.708 0.289 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.731 ' CB ' HG21 ' A' ' 63' ' ' THR . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.666 ' HE2' HG21 ' A' ' 97' ' ' VAL . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 35' ' ' ILE . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 83' ' ' LYS . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 86' ' ' VAL . 1.6 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 50' ' ' VAL . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.495 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' HG21 ' A' ' 56' ' ' THR . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 m120 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 53' ' ' PHE . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CB ' ' A' ' 23' ' ' VAL . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' O ' HD11 ' A' ' 78' ' ' ILE . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.76 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.572 HG21 HG23 ' A' ' 73' ' ' VAL . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' HD2' HG23 ' B' ' 123' ' ' VAL . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.892 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.76 ' CD1' HG11 ' A' ' 73' ' ' VAL . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.519 ' NE2' HG22 ' B' ' 125' ' ' ILE . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 89' ' ' MET . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 ' HE2' ' A' ' 27' ' ' LYS . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.504 ' C ' HD12 ' A' ' 99' ' ' ILE . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.557 HG23 ' HD2' ' A' ' 83' ' ' LYS . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.519 HG22 ' NE2' ' A' ' 91' ' ' GLN . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.733 0.301 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.751 HD21 HG21 ' A' ' 63' ' ' THR . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' B' ' 125' ' ' ILE . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.645 HG23 ' HZ3' ' A' ' 27' ' ' LYS . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.518 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 86' ' ' VAL . 6.2 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.785 0.326 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.471 ' H ' HG12 ' A' ' 50' ' ' VAL . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.751 HG21 HD21 ' A' ' 25' ' ' LEU . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 63' ' ' THR . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.584 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' THR . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.477 ' HE2' HG11 ' A' ' 73' ' ' VAL . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG13 HG11 ' A' ' 97' ' ' VAL . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.61 HG11 ' HE2' ' A' ' 27' ' ' LYS . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.428 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.618 HG11 ' CB ' ' A' ' 87' ' ' ALA . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.445 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 17.0 t . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.467 0.175 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' VAL . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.824 HD12 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.806 ' HE2' HG21 ' A' ' 97' ' ' VAL . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 30' ' ' GLN . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 35' ' ' ILE . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.744 0.307 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 50' ' ' VAL . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 56' ' ' THR . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 53' ' ' PHE . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.582 ' O ' HD11 ' A' ' 78' ' ' ILE . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.513 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 90' ' ' ILE . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 84' ' ' VAL . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 47' ' ' LEU . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.85 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.829 HG21 HD13 ' B' ' 125' ' ' ILE . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HG3' HG22 ' B' ' 125' ' ' ILE . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 89' ' ' MET . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.806 HG21 ' HE2' ' A' ' 27' ' ' LYS . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.711 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.824 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 63' ' ' THR . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 123' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 124' ' ' LYS . . . . . 0.428 ' NZ ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 125' ' ' ILE . . . . . 0.829 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.649 HG22 ' HG ' ' A' ' 104' ' ' LEU . 7.5 p . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.32 114.31 33.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 25' ' ' LEU . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' HD12 ' A' ' 32' ' ' LEU . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 125' ' ' ILE . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 35' ' ' ILE . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.0 170.05 42.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.58 -139.47 4.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -166.7 149.81 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.107 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.08 25.25 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.17 -46.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.59 60.61 45.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.94 -7.14 20.51 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.637 2.224 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.31 100.73 5.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? -83.62 135.31 34.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.822 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 68' ' ' ASP . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG21 ' OG ' ' B' ' 122' ' ' SER . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.5 m120 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.593 ' O ' HD11 ' A' ' 78' ' ' ILE . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' OD1' ' A' ' 102' ' ' ASN . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG11 ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.82 HD22 ' HA ' ' A' ' 97' ' ' VAL . 35.8 m120 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 70' ' ' ILE . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' THR . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.787 ' CD1' HG11 ' A' ' 73' ' ' VAL . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' MET . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.82 ' HA ' HD22 ' A' ' 74' ' ' ASN . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 98' ' ' THR . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.2 m80 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.649 ' HG ' HG22 ' A' ' 18' ' ' THR . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 50' ' ' VAL . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.587 HG23 ' HD2' ' A' ' 83' ' ' LYS . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.607 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.587 HG22 ' HG ' ' A' ' 104' ' ' LEU . 61.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.848 0.356 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.0 90.99 50.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 63' ' ' THR . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.828 ' HE2' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 125' ' ' ILE . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 35' ' ' ILE . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -166.6 170.0 40.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.24 -138.09 3.3 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.605 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.24 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 65.85 -76.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.56 -35.78 77.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.45 64.89 11.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 -40.74 62.96 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.227 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -61.64 133.59 55.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 39' ' ' GLY . 1.5 mm? -96.86 131.52 43.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 70' ' ' ILE . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 51' ' ' GLN . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 52' ' ' VAL . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.616 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 23' ' ' VAL . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' HD11 ' A' ' 49' ' ' ILE . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.828 HG11 ' CD1' ' A' ' 90' ' ' ILE . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 97' ' ' VAL . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' B' ' 123' ' ' VAL . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 82' ' ' THR . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.828 ' CD1' HG11 ' A' ' 73' ' ' VAL . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' MET . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.828 HG21 ' HE2' ' A' ' 27' ' ' LYS . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.578 HD13 HG13 ' A' ' 73' ' ' VAL . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 64' ' ' VAL . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.676 ' O ' HD12 ' A' ' 104' ' ' LEU . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 102' ' ' ASN . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 83' ' ' LYS . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 104' ' ' LEU . 2.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.905 0.384 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.6 p -121.87 107.74 35.46 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' A' ' 63' ' ' THR . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 96' ' ' GLU . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 58' ' ' ALA . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.746 ' HE2' HG11 ' A' ' 97' ' ' VAL . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 7.1 mm100 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 35' ' ' ILE . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 33' ' ' ILE . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.86 165.22 50.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.25 93.91 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.63 -54.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.369 . . . . 0.0 111.112 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.94 -55.63 2.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.816 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.19 29.22 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.776 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.44 127.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 -11.76 26.14 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.343 2.029 . . . . 0.0 112.902 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.8 p -155.54 164.75 38.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.934 0.397 . . . . 0.0 111.125 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 HG21 ' A' ' 86' ' ' VAL . 1.1 tp -69.96 170.07 12.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 68' ' ' ASP . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.604 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.678 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 49' ' ' ILE . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.433 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 86' ' ' VAL . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 86' ' ' VAL . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 85' ' ' GLU . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 84' ' ' VAL . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.863 HG21 HD22 ' A' ' 47' ' ' LEU . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 125' ' ' ILE . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG11 ' HE2' ' A' ' 27' ' ' LYS . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 63' ' ' THR . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.955 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.94 HG22 HD11 ' A' ' 104' ' ' LEU . 4.9 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.911 0.386 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.67 97.45 50.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.409 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.726 ' CG2' HG21 ' A' ' 63' ' ' THR . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 99' ' ' ILE . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.784 ' HD3' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HD3' ' A' ' 27' ' ' LYS . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 33' ' ' ILE . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -162.13 156.8 28.5 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -169.95 88.82 0.09 OUTLIER Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.408 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.04 -29.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.24 -32.56 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.21 29.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.63 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER 172.56 75.11 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.483 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 -14.32 44.07 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.457 2.104 . . . . 0.0 112.591 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 7.6 m -82.64 135.4 35.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -90.59 151.12 21.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 68' ' ' ASP . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 m120 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 53' ' ' PHE . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.726 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 23' ' ' VAL . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 99' ' ' ILE . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CE ' ' A' ' 89' ' ' MET . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 47' ' ' LEU . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.458 ' CE ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.799 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.536 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' CD2' ' HB3' ' A' ' 22' ' ' LYS . 4.4 m80 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 18' ' ' THR . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.684 0.278 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.1 81.06 15.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 HG21 ' A' ' 63' ' ' THR . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 63' ' ' THR . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 97' ' ' VAL . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 30' ' ' GLN . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.613 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 49' ' ' ILE . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.79 167.85 40.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.59 -130.86 4.59 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -175.8 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.24 -30.32 60.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -115.46 -38.91 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.06 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.64 87.54 45.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 -27.6 20.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.601 2.2 . . . . 0.0 112.309 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 t -68.71 134.36 49.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.17 135.39 45.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 51' ' ' GLN . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.616 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.671 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' THR . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.6 m120 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 53' ' ' PHE . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.658 HG21 HG21 ' A' ' 23' ' ' VAL . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 63' ' ' THR . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.725 HG11 HD13 ' A' ' 90' ' ' ILE . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 85' ' ' GLU . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 84' ' ' VAL . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 82' ' ' THR . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.811 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.725 HD13 HG11 ' A' ' 73' ' ' VAL . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' MET . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 27' ' ' LYS . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 104' ' ' LEU . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 103' ' ' LYS . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.92 95.0 5.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 63' ' ' THR . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 98' ' ' THR . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.866 ' NZ ' HG23 ' A' ' 33' ' ' ILE . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.866 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 HD11 ' B' ' 125' ' ' ILE . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.06 165.34 38.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 82' ' ' THR . . . -102.15 -124.58 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.577 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.738 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -160.76 -64.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -90.67 -61.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -68.42 -47.74 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.035 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 m -120.64 75.91 26.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 -11.69 26.47 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 0.0 112.604 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.1 147.77 32.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.872 0.367 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.475 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? -115.48 154.42 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.719 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.77 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.3 m120 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.705 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 23' ' ' VAL . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 63' ' ' THR . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 52' ' ' VAL . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.77 ' HB2' HD12 ' A' ' 49' ' ' ILE . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 78' ' ' ILE . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG21 ' CD1' ' A' ' 90' ' ' ILE . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.623 ' HE ' HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' B' ' 123' ' ' VAL . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 84' ' ' VAL . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 82' ' ' THR . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' B' ' 125' ' ' ILE . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.758 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.815 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 89' ' ' MET . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HE2' ' A' ' 27' ' ' LYS . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 97' ' ' VAL . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.699 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.338 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.7 p -120.98 94.34 48.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 64' ' ' VAL . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 98' ' ' THR . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.815 ' NZ ' HG21 ' A' ' 97' ' ' VAL . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 30' ' ' GLN . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 35' ' ' ILE . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' ILE . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.07 145.79 9.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.95 -121.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.518 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -168.86 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 111.198 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -85.55 -52.66 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.57 19.45 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.94 64.27 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 -9.1 23.42 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.561 2.174 . . . . 0.0 112.602 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 67.2 m -69.35 127.99 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.816 0.341 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.4 mm? -110.85 144.21 40.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.504 ' HA ' HG22 ' A' ' 70' ' ' ILE . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 51' ' ' GLN . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.3 m120 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 53' ' ' PHE . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.714 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG13 HG11 ' A' ' 23' ' ' VAL . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 48' ' ' TYR . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.536 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 71' ' ' THR . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 41' ' ' ALA . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 82' ' ' THR . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 82' ' ' THR . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.917 HG21 HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' B' ' 125' ' ' ILE . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.47 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.714 ' OH ' HG22 ' A' ' 63' ' ' THR . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.917 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 HD23 ' A' ' 104' ' ' LEU . 73.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.8 91.42 48.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.739 ' CG2' HG21 ' A' ' 63' ' ' THR . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 99' ' ' ILE . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HE2' HG22 ' A' ' 90' ' ' ILE . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.804 ' HG3' HD12 ' A' ' 32' ' ' LEU . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.804 HD12 ' HG3' ' A' ' 30' ' ' GLN . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 35' ' ' ILE . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -170.05 145.4 9.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.31 4.06 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.84 -76.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -76.29 -35.76 58.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -91.36 -31.13 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.4 m -151.91 79.86 6.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -23.3 42.76 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.41 128.8 37.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.993 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.5 mm? -101.5 148.78 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.71 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.904 HD12 ' HB2' ' A' ' 68' ' ' ASP . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 56' ' ' THR . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.4 m120 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 53' ' ' PHE . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.739 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.904 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 104' ' ' LEU . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.525 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 70' ' ' ILE . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.805 HG11 ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' VAL . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 82' ' ' THR . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.697 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.805 ' CD1' HG11 ' A' ' 73' ' ' VAL . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 89' ' ' MET . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG11 ' HE3' ' A' ' 27' ' ' LYS . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.656 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 25' ' ' LEU . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 104' ' ' LEU . 66.3 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -136.22 97.84 11.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 63' ' ' THR . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD12 HD13 ' A' ' 99' ' ' ILE . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 26' ' ' GLN . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 47' ' ' LEU . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.76 169.58 42.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.22 -130.02 6.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.77 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -73.79 -45.7 49.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -114.77 -37.8 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.86 78.69 5.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.85 -42.04 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.9 m -63.22 107.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.1 mm? -72.65 137.65 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.635 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 53' ' ' PHE . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.691 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 58' ' ' ALA . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 52' ' ' VAL . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB2' HD12 ' A' ' 49' ' ' ILE . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 102' ' ' ASN . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 90' ' ' ILE . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HD3' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.734 ' CD1' HG11 ' A' ' 73' ' ' VAL . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.686 HD13 HD12 ' A' ' 25' ' ' LEU . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.481 HD21 HG21 ' A' ' 71' ' ' THR . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 18' ' ' THR . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 87' ' ' ALA . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.58 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 104' ' ' LEU . 3.8 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.98 100.29 11.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 97' ' ' VAL . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.767 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 30' ' ' GLN . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 35' ' ' ILE . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.96 168.68 41.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.41 -124.66 5.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.563 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -175.37 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.036 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -103.39 -47.2 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.33 -30.67 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.66 64.19 56.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.1 -28.63 70.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.531 2.154 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.16 132.69 37.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 86' ' ' VAL . 8.9 mp -99.74 169.92 8.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.794 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HA ' HG22 ' A' ' 70' ' ' ILE . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 68' ' ' ASP . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' N ' HG12 ' A' ' 52' ' ' VAL . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 m120 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.758 ' CB ' HD13 ' A' ' 49' ' ' ILE . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.537 HG22 ' HA ' ' A' ' 48' ' ' TYR . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.926 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.0 t30 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 47' ' ' LEU . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.926 ' CD1' HG21 ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG3' HG22 ' B' ' 125' ' ' ILE . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 89' ' ' MET . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 90' ' ' ILE . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 99' ' ' ILE . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 98' ' ' THR . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 18' ' ' THR . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 122' ' ' SER . . . . . 0.568 ' HB3' HG21 ' A' ' 50' ' ' VAL . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG ' ' A' ' 104' ' ' LEU . 68.1 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.89 94.79 45.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' HB ' HG21 ' A' ' 63' ' ' THR . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 97' ' ' VAL . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.22 41.21 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.34 -135.9 4.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -159.31 -48.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -53.75 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -83.22 -30.5 27.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -135.39 64.43 59.25 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.74 -34.11 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.622 2.214 . . . . 0.0 112.22 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.4 ' O ' HD22 ' A' ' 47' ' ' LEU . 2.0 m -60.01 152.26 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.4 mm? -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.761 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' OH ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' B' ' 122' ' ' SER . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 15.0 m120 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 53' ' ' PHE . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.734 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 49' ' ' ILE . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.528 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 82' ' ' THR . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' B' ' 125' ' ' ILE . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' MET . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 33' ' ' ILE . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 98' ' ' THR . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.836 ' HG ' HG22 ' A' ' 18' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 122' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.633 HD13 ' HB ' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.05 90.64 16.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' CG2' HG21 ' A' ' 63' ' ' THR . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 99' ' ' ILE . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CD1' HD11 ' A' ' 33' ' ' ILE . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.32 153.82 25.19 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . -168.89 84.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.551 ' H ' HG23 ' A' ' 82' ' ' THR . . . -58.0 -177.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.188 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 61.54 17.69 8.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.298 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 14.6 p90 172.0 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.619 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.4 m -146.53 75.11 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.18 -23.5 33.37 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.643 2.229 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 31.1 m -57.56 133.08 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -99.74 141.99 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 70' ' ' ILE . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.476 ' H ' HG12 ' A' ' 50' ' ' VAL . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.3 m120 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 23' ' ' VAL . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 58' ' ' ALA . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 78' ' ' ILE . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 70' ' ' ILE . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 41' ' ' ALA . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 82' ' ' THR . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 87' ' ' ALA . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.852 ' CD1' HG21 ' A' ' 73' ' ' VAL . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' ILE . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG11 ' HE2' ' A' ' 27' ' ' LYS . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 HD21 ' A' ' 104' ' ' LEU . 13.2 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.27 98.7 51.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 63' ' ' THR . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' GLU . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 23' ' ' VAL . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HD12 ' A' ' 32' ' ' LEU . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 30' ' ' GLN . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 35' ' ' ILE . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.69 HD11 HD11 ' B' ' 125' ' ' ILE . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -158.92 167.47 34.8 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' C ' HG23 ' A' ' 82' ' ' THR . . . -129.28 -126.65 2.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.503 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.7 158.2 12.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 111.174 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 67.4 -69.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.36 -39.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 56.4 m -125.81 69.33 64.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.97 -30.12 14.2 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.312 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.49 145.04 49.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.8 mm? -117.9 118.55 32.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.516 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.799 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 64' ' ' VAL . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.799 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 23' ' ' VAL . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.595 ' HB2' HD12 ' A' ' 49' ' ' ILE . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.586 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 90' ' ' ILE . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.57 HG23 ' C ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' H ' HG22 ' A' ' 82' ' ' THR . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 82' ' ' THR . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.785 HG21 HD13 ' B' ' 125' ' ' ILE . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 97' ' ' VAL . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 24' ' ' THR . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 93' ' ' VAL . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CD2' HG12 ' A' ' 64' ' ' VAL . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 18' ' ' THR . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.785 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.2 91.24 31.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 100' ' ' HIS . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.814 HD12 HD13 ' A' ' 99' ' ' ILE . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 HD11 ' B' ' 125' ' ' ILE . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.06 164.35 37.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.94 -119.73 3.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -175.44 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -81.81 -69.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -71.94 -47.14 54.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.98 74.45 5.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.06 -21.84 36.17 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.48 2.12 . . . . 0.0 112.435 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.64 121.8 11.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.04 127.21 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.7 m120 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.713 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HB1' ' A' ' 58' ' ' ALA . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 90' ' ' ILE . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.5 t30 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' CE ' ' A' ' 89' ' ' MET . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' H ' HG22 ' A' ' 82' ' ' THR . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 85' ' ' GLU . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 84' ' ' VAL . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 82' ' ' THR . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.429 ' CE ' HG22 ' A' ' 78' ' ' ILE . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.939 HG21 HD13 ' B' ' 125' ' ' ILE . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 97' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 93' ' ' VAL . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.814 HD13 HD12 ' A' ' 25' ' ' LEU . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.414 ' CD2' ' HB3' ' A' ' 22' ' ' LYS . 4.4 m80 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.668 HG23 ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.773 0.321 . . . . 0.0 110.819 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.8 p -106.49 123.57 38.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 25' ' ' LEU . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 96' ' ' GLU . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HE2' HG21 ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.443 HD21 ' HG2' ' A' ' 91' ' ' GLN . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 35' ' ' ILE . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.479 HD11 HD11 ' B' ' 125' ' ' ILE . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.521 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.65 143.08 7.69 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.6 -128.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -173.31 -41.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -32.61 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.0 -31.73 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.49 64.37 63.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.11 -29.53 66.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.587 2.191 . . . . 0.0 112.243 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 124.46 22.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 86' ' ' VAL . 7.2 mp -102.55 138.5 39.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 68' ' ' ASP . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.504 HG21 ' CB ' ' B' ' 122' ' ' SER . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.45 ' HG2' HG12 ' A' ' 50' ' ' VAL . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 56' ' ' THR . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 14.1 m120 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' PHE . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.885 ' HB2' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 78' ' ' ILE . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 90' ' ' ILE . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.587 ' OD1' HG21 ' A' ' 93' ' ' VAL . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' HG22 ' A' ' 78' ' ' ILE . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 1.008 HG21 HD13 ' B' ' 125' ' ' ILE . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 32' ' ' LEU . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.587 HG21 ' OD1' ' A' ' 74' ' ' ASN . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HB2' HG22 ' A' ' 24' ' ' THR . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG21 ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 24' ' ' THR . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 99' ' ' ILE . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' CD1' HG23 ' A' ' 18' ' ' THR . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 122' ' ' SER . . . . . 0.504 ' CB ' HG21 ' A' ' 50' ' ' VAL . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 1.008 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 104' ' ' LEU . 43.3 p . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.72 79.1 30.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.408 ' HA ' ' ND2' ' A' ' 102' ' ' ASN . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 96' ' ' GLU . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.837 ' HE2' HG21 ' A' ' 97' ' ' VAL . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.498 ' HB2' HD12 ' A' ' 32' ' ' LEU . 5.4 mm100 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 30' ' ' GLN . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.769 HG23 ' HD3' ' A' ' 27' ' ' LYS . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.11 156.52 27.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.88 -128.28 4.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.25 147.45 9.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 65.07 -75.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.8 -34.33 52.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.2 60.9 56.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.993 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -7.07 18.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.532 2.154 . . . . 0.0 112.701 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 85.5 m -76.88 127.7 33.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.019 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.5 mm? -108.84 141.72 40.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.587 ' HA ' HG22 ' A' ' 70' ' ' ILE . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 51' ' ' GLN . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 50' ' ' VAL . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 53' ' ' PHE . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 m120 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 53' ' ' PHE . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 48' ' ' TYR . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 86' ' ' VAL . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.85 ' CD1' HG21 ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' MET . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HE2' ' A' ' 27' ' ' LYS . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.561 HD13 HG23 ' A' ' 73' ' ' VAL . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' ND2' ' HA ' ' A' ' 20' ' ' PRO . 7.1 m120 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 18' ' ' THR . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.672 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.57 90.52 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 63' ' ' THR . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 99' ' ' ILE . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 33' ' ' ILE . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 30' ' ' GLN . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 97' ' ' VAL . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.05 169.97 42.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.18 -116.83 1.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.406 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.22 132.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 68.6 -68.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -69.09 -33.98 74.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 69.09 6.8 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.23 -24.55 19.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.36 114.82 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 83' ' ' LYS . 7.8 mp -102.55 129.09 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 50' ' ' VAL . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 51' ' ' GLN . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' N ' HG12 ' A' ' 52' ' ' VAL . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.0 m120 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.601 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 101' ' ' TYR . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 48' ' ' TYR . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 86' ' ' VAL . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 47' ' ' LEU . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 47' ' ' LEU . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 89' ' ' MET . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 33' ' ' ILE . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.693 ' C ' HD12 ' A' ' 99' ' ' ILE . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' A' ' 64' ' ' VAL . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 83' ' ' LYS . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.486 HG22 ' HG ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.32 91.71 17.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.056 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.731 ' CB ' HG21 ' A' ' 63' ' ' THR . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.666 ' HE2' HG21 ' A' ' 97' ' ' VAL . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 5.0 mm100 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 35' ' ' ILE . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 83' ' ' LYS . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.14 170.06 42.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.7 -124.37 5.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -175.34 -54.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.93 -62.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -79.07 -24.44 43.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.66 74.65 12.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.937 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.3 -26.3 35.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.527 2.151 . . . . 0.0 112.313 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.34 133.9 55.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 86' ' ' VAL . 1.6 mm? -97.65 161.92 13.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 50' ' ' VAL . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.495 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' HG21 ' A' ' 56' ' ' THR . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.9 m120 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 53' ' ' PHE . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CB ' ' A' ' 23' ' ' VAL . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' O ' HD11 ' A' ' 78' ' ' ILE . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.76 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.572 HG21 HG23 ' A' ' 73' ' ' VAL . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' HD2' HG23 ' B' ' 123' ' ' VAL . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.892 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.76 ' CD1' HG11 ' A' ' 73' ' ' VAL . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.519 ' NE2' HG22 ' B' ' 125' ' ' ILE . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 89' ' ' MET . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 ' HE2' ' A' ' 27' ' ' LYS . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.504 ' C ' HD12 ' A' ' 99' ' ' ILE . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HG ' HG22 ' A' ' 18' ' ' THR . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.557 HG23 ' HD2' ' A' ' 83' ' ' LYS . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.519 HG22 ' NE2' ' A' ' 91' ' ' GLN . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.38 86.02 55.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.751 HD21 HG21 ' A' ' 63' ' ' THR . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' B' ' 125' ' ' ILE . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.645 HG23 ' HZ3' ' A' ' 27' ' ' LYS . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.518 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . -170.1 138.75 5.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -63.57 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.64 -163.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.711 0.291 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 64.37 59.77 0.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.997 0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 29.35 17.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 68.8 m -150.63 64.58 6.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 23.6 Cg_exo -64.05 -47.13 6.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.636 2.224 . . . . 0.0 112.088 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.2 169.63 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 86' ' ' VAL . 6.2 mp -123.47 132.23 53.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.471 ' H ' HG12 ' A' ' 50' ' ' VAL . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.751 HG21 HD21 ' A' ' 25' ' ' LEU . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 63' ' ' THR . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.584 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' THR . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.477 ' HE2' HG11 ' A' ' 73' ' ' VAL . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG13 HG11 ' A' ' 97' ' ' VAL . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.61 HG11 ' HE2' ' A' ' 27' ' ' LYS . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.428 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.7 m80 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.618 HG11 ' CB ' ' A' ' 87' ' ' ALA . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.445 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 17.0 t -89.78 106.75 15.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' VAL . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.824 HD12 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.806 ' HE2' HG21 ' A' ' 97' ' ' VAL . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 30' ' ' GLN . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 35' ' ' ILE . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.11 27.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.99 -38.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.652 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' HG23 ' A' ' 82' ' ' THR . . . 65.54 160.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 70.04 -64.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.012 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -107.29 -30.73 8.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.107 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 40.9 m -137.17 65.77 51.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 16.6 Cg_exo -67.43 -28.27 39.07 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.704 2.27 . . . . 0.0 112.189 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.91 97.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -75.97 169.98 17.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 50' ' ' VAL . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 56' ' ' THR . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 53' ' ' PHE . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.582 ' O ' HD11 ' A' ' 78' ' ' ILE . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.513 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 90' ' ' ILE . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 84' ' ' VAL . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 47' ' ' LEU . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.85 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.829 HG21 HD13 ' B' ' 125' ' ' ILE . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HG3' HG22 ' B' ' 125' ' ' ILE . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 89' ' ' MET . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.806 HG21 ' HE2' ' A' ' 27' ' ' LYS . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.711 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.824 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 63' ' ' THR . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 18' ' ' THR . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 123' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 124' ' ' LYS . . . . . 0.428 ' NZ ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 125' ' ' ILE . . . . . 0.829 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.587 0.232 . . . . 0.0 111.063 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 25' ' ' LEU . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.446 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' HD12 ' A' ' 32' ' ' LEU . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 125' ' ' ILE . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 35' ' ' ILE . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.83 0.348 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 68' ' ' ASP . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG21 ' OG ' ' B' ' 122' ' ' SER . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.593 ' O ' HD11 ' A' ' 78' ' ' ILE . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' OD1' ' A' ' 102' ' ' ASN . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.787 HG11 ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.644 HD21 HG13 ' A' ' 97' ' ' VAL . 71.5 m-80 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 70' ' ' ILE . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' THR . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.787 ' CD1' HG11 ' A' ' 73' ' ' VAL . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' MET . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 74' ' ' ASN . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 98' ' ' THR . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.598 HD12 ' O ' ' A' ' 102' ' ' ASN . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 50' ' ' VAL . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.587 HG23 ' HD2' ' A' ' 83' ' ' LYS . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.607 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.654 0.264 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 63' ' ' THR . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.828 ' HE2' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 125' ' ' ILE . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 35' ' ' ILE . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 39' ' ' GLY . 1.5 mm? . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 70' ' ' ILE . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 51' ' ' GLN . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.484 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 52' ' ' VAL . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.616 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 23' ' ' VAL . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' HD11 ' A' ' 49' ' ' ILE . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.828 HG11 ' CD1' ' A' ' 90' ' ' ILE . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 97' ' ' VAL . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' B' ' 123' ' ' VAL . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 82' ' ' THR . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.828 ' CD1' HG11 ' A' ' 73' ' ' VAL . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' MET . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.828 HG21 ' HE2' ' A' ' 27' ' ' LYS . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.578 HD13 HG13 ' A' ' 73' ' ' VAL . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 64' ' ' VAL . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.676 ' O ' HD12 ' A' ' 104' ' ' LEU . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 102' ' ' ASN . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 83' ' ' LYS . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.6 p . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.572 0.225 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' A' ' 63' ' ' THR . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 96' ' ' GLU . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 58' ' ' ALA . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.746 ' HE2' HG11 ' A' ' 97' ' ' VAL . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 35' ' ' ILE . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 33' ' ' ILE . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 HG21 ' A' ' 86' ' ' VAL . 1.1 tp . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.8 0.334 . . . . 0.0 110.789 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 68' ' ' ASP . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.604 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.678 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 49' ' ' ILE . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.433 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.781 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 86' ' ' VAL . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 86' ' ' VAL . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 85' ' ' GLU . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 84' ' ' VAL . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.863 HG21 HD22 ' A' ' 47' ' ' LEU . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 125' ' ' ILE . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.746 HG11 ' HE2' ' A' ' 27' ' ' LYS . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 63' ' ' THR . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.955 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.563 0.22 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.726 ' CG2' HG21 ' A' ' 63' ' ' THR . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 99' ' ' ILE . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.784 ' HD3' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HD3' ' A' ' 27' ' ' LYS . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 33' ' ' ILE . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.654 0.264 . . . . 0.0 110.758 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 68' ' ' ASP . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 53' ' ' PHE . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.726 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 23' ' ' VAL . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 99' ' ' ILE . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CE ' ' A' ' 89' ' ' MET . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 47' ' ' LEU . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.458 ' CE ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.799 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.536 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.625 0.25 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 HG21 ' A' ' 63' ' ' THR . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 63' ' ' THR . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 97' ' ' VAL . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 30' ' ' GLN . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.613 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 49' ' ' ILE . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.738 0.304 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.4 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 51' ' ' GLN . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.616 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.671 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' THR . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 53' ' ' PHE . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.658 HG21 HG21 ' A' ' 23' ' ' VAL . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 63' ' ' THR . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.725 HG11 HD13 ' A' ' 90' ' ' ILE . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.48 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 85' ' ' GLU . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 84' ' ' VAL . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 82' ' ' THR . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.811 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.725 HD13 HG11 ' A' ' 73' ' ' VAL . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' MET . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 27' ' ' LYS . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 104' ' ' LEU . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 103' ' ' LYS . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.66 0.266 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 63' ' ' THR . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 98' ' ' THR . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.866 ' NZ ' HG23 ' A' ' 33' ' ' ILE . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.866 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 HD11 ' B' ' 125' ' ' ILE . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.475 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.697 0.284 . . . . 0.0 110.719 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.77 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.705 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 23' ' ' VAL . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 63' ' ' THR . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 52' ' ' VAL . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.77 ' HB2' HD12 ' A' ' 49' ' ' ILE . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 78' ' ' ILE . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.815 HG21 ' CD1' ' A' ' 90' ' ' ILE . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.623 ' HE ' HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' B' ' 123' ' ' VAL . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 84' ' ' VAL . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 82' ' ' THR . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' B' ' 125' ' ' ILE . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.758 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.815 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.496 HE21 HG22 ' B' ' 125' ' ' ILE . 24.9 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 89' ' ' MET . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HE2' ' A' ' 27' ' ' LYS . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 97' ' ' VAL . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.699 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.7 p . . . . . 0 CA--C 1.53 0.179 0 CA-C-O 120.717 0.294 . . . . 0.0 111.094 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 64' ' ' VAL . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 98' ' ' THR . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.815 ' NZ ' HG21 ' A' ' 97' ' ' VAL . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 30' ' ' GLN . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 35' ' ' ILE . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' ILE . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.589 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.4 mm? . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.719 0.295 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.504 ' HA ' HG22 ' A' ' 70' ' ' ILE . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 51' ' ' GLN . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 53' ' ' PHE . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.714 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.689 HG13 HG11 ' A' ' 23' ' ' VAL . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 48' ' ' TYR . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.536 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 71' ' ' THR . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.484 ' O ' HG23 ' A' ' 86' ' ' VAL . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 82' ' ' THR . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 82' ' ' THR . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.917 HG21 HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' B' ' 125' ' ' ILE . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.47 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.714 ' OH ' HG22 ' A' ' 63' ' ' THR . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.413 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.917 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.527 0.074 0 CA-C-O 120.686 0.279 . . . . 0.0 111.107 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.739 ' CG2' HG21 ' A' ' 63' ' ' THR . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 99' ' ' ILE . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HE2' HG22 ' A' ' 90' ' ' ILE . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.804 ' HG3' HD12 ' A' ' 32' ' ' LEU . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.804 HD12 ' HG3' ' A' ' 30' ' ' GLN . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 35' ' ' ILE . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.5 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.815 0.341 . . . . 0.0 110.71 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.904 HD12 ' HB2' ' A' ' 68' ' ' ASP . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 56' ' ' THR . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 53' ' ' PHE . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.739 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.904 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 104' ' ' LEU . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.525 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 70' ' ' ILE . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.805 HG11 ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' VAL . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 82' ' ' THR . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.503 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.697 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.805 ' CD1' HG11 ' A' ' 73' ' ' VAL . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 89' ' ' MET . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.495 HG11 ' HE3' ' A' ' 27' ' ' LYS . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.656 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 25' ' ' LEU . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.663 0.268 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 63' ' ' THR . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.686 HD12 HD13 ' A' ' 99' ' ' ILE . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 26' ' ' GLN . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 47' ' ' LEU . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.1 mm? . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.748 0.309 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.635 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 53' ' ' PHE . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.691 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 58' ' ' ALA . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 52' ' ' VAL . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB2' HD12 ' A' ' 49' ' ' ILE . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 102' ' ' ASN . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 90' ' ' ILE . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HD3' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.734 ' CD1' HG11 ' A' ' 73' ' ' VAL . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.686 HD13 HD12 ' A' ' 25' ' ' LEU . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.481 HD21 HG21 ' A' ' 71' ' ' THR . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 87' ' ' ALA . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.58 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.556 0.217 . . . . 0.0 111.057 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 97' ' ' VAL . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.767 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 30' ' ' GLN . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 35' ' ' ILE . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 86' ' ' VAL . 8.9 mp . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.777 0.323 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HA ' HG22 ' A' ' 70' ' ' ILE . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 68' ' ' ASP . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.48 ' N ' HG12 ' A' ' 52' ' ' VAL . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.758 ' CB ' HD13 ' A' ' 49' ' ' ILE . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.537 HG22 ' HA ' ' A' ' 48' ' ' TYR . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.926 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 47' ' ' LEU . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.926 ' CD1' HG21 ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG3' HG22 ' B' ' 125' ' ' ILE . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 89' ' ' MET . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 90' ' ' ILE . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 99' ' ' ILE . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 98' ' ' THR . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.568 ' HB3' HG21 ' A' ' 50' ' ' VAL . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t . . . . . 0 N--CA 1.457 -0.12 0 CA-C-O 120.591 0.234 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.532 ' HB ' HG21 ' A' ' 63' ' ' THR . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 97' ' ' VAL . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.4 mm? . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.927 0.394 . . . . 0.0 110.761 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.47 ' OH ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' B' ' 122' ' ' SER . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 53' ' ' PHE . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.734 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 49' ' ' ILE . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.528 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 82' ' ' THR . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' B' ' 125' ' ' ILE . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' MET . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 33' ' ' ILE . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 98' ' ' THR . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.507 HD12 ' O ' ' A' ' 102' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.633 HD13 ' HB ' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.738 0.304 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.557 ' CG2' HG21 ' A' ' 63' ' ' THR . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 99' ' ' ILE . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.575 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CD1' HD11 ' A' ' 33' ' ' ILE . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.86 0.362 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 70' ' ' ILE . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.476 ' H ' HG12 ' A' ' 50' ' ' VAL . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 23' ' ' VAL . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 58' ' ' ALA . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 78' ' ' ILE . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 70' ' ' ILE . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.481 HG22 ' H ' ' A' ' 83' ' ' LYS . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 82' ' ' THR . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 87' ' ' ALA . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.852 ' CD1' HG21 ' A' ' 73' ' ' VAL . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' ILE . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.692 HG11 ' HE2' ' A' ' 27' ' ' LYS . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.409 ' N ' ' CD2' ' A' ' 100' ' ' HIS . 5.1 m-70 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 104' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 CA--C 1.528 0.127 0 CA-C-O 120.58 0.229 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 63' ' ' THR . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' GLU . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 23' ' ' VAL . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.539 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HD12 ' A' ' 32' ' ' LEU . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 30' ' ' GLN . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 35' ' ' ILE . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.69 HD11 HD11 ' B' ' 125' ' ' ILE . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.8 mm? . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.8 0.333 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.516 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.799 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 64' ' ' VAL . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.799 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 23' ' ' VAL . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.595 ' HB2' HD12 ' A' ' 49' ' ' ILE . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.586 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 90' ' ' ILE . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.475 ' H ' HG22 ' A' ' 82' ' ' THR . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 82' ' ' THR . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.785 HG21 HD13 ' B' ' 125' ' ' ILE . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.696 HE21 HG22 ' B' ' 125' ' ' ILE . 43.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 97' ' ' VAL . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 24' ' ' THR . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 93' ' ' VAL . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CD2' HG12 ' A' ' 64' ' ' VAL . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.785 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.663 0.268 . . . . 0.0 111.14 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.814 HD12 HD13 ' A' ' 99' ' ' ILE . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 HD11 ' B' ' 125' ' ' ILE . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.744 0.307 . . . . 0.0 110.746 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.671 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.713 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HB1' ' A' ' 58' ' ' ALA . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 90' ' ' ILE . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' CE ' ' A' ' 89' ' ' MET . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.479 ' H ' HG22 ' A' ' 82' ' ' THR . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 85' ' ' GLU . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 84' ' ' VAL . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 82' ' ' THR . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.429 ' CE ' HG22 ' A' ' 78' ' ' ILE . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.939 HG21 HD13 ' B' ' 125' ' ' ILE . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 97' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 93' ' ' VAL . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.814 HD13 HD12 ' A' ' 25' ' ' LEU . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.8 p . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.62 0.248 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 25' ' ' LEU . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 96' ' ' GLU . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HE2' HG21 ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.443 HD21 ' HG2' ' A' ' 91' ' ' GLN . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 35' ' ' ILE . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.479 HD11 HD11 ' B' ' 125' ' ' ILE . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.521 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 86' ' ' VAL . 7.2 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.81 0.338 . . . . 0.0 110.912 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 68' ' ' ASP . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.504 HG21 ' CB ' ' B' ' 122' ' ' SER . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.45 ' HG2' HG12 ' A' ' 50' ' ' VAL . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 56' ' ' THR . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' PHE . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.885 ' HB2' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 78' ' ' ILE . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 90' ' ' ILE . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.587 ' OD1' HG21 ' A' ' 93' ' ' VAL . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' HG22 ' A' ' 78' ' ' ILE . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 1.008 HG21 HD13 ' B' ' 125' ' ' ILE . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 32' ' ' LEU . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.587 HG21 ' OD1' ' A' ' 74' ' ' ASN . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HB2' HG22 ' A' ' 24' ' ' THR . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.724 HG21 ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 24' ' ' THR . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 99' ' ' ILE . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . 0.504 ' CB ' HG21 ' A' ' 50' ' ' VAL . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 1.008 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.681 0.276 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 96' ' ' GLU . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.837 ' HE2' HG21 ' A' ' 97' ' ' VAL . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.498 ' HB2' HD12 ' A' ' 32' ' ' LEU . 1.5 mm-40 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 30' ' ' GLN . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.769 HG23 ' HD3' ' A' ' 27' ' ' LYS . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.5 mm? . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.84 0.353 . . . . 0.0 110.804 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.587 ' HA ' HG22 ' A' ' 70' ' ' ILE . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 51' ' ' GLN . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 50' ' ' VAL . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 53' ' ' PHE . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.505 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 53' ' ' PHE . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 48' ' ' TYR . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 86' ' ' VAL . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.85 ' CD1' HG21 ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' MET . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HE2' ' A' ' 27' ' ' LYS . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.561 HD13 HG23 ' A' ' 73' ' ' VAL . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.672 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t . . . . . 0 C--O 1.232 0.16 0 CA-C-O 120.671 0.272 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 63' ' ' THR . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 99' ' ' ILE . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 33' ' ' ILE . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 30' ' ' GLN . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 97' ' ' VAL . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 83' ' ' LYS . 7.8 mp . . . . . 0 CA--C 1.527 0.061 0 CA-C-O 120.741 0.305 . . . . 0.0 110.644 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 50' ' ' VAL . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 51' ' ' GLN . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.506 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.477 ' N ' HG12 ' A' ' 52' ' ' VAL . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.601 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 101' ' ' TYR . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 48' ' ' TYR . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 86' ' ' VAL . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 47' ' ' LEU . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 47' ' ' LEU . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 89' ' ' MET . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 33' ' ' ILE . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.693 ' C ' HD12 ' A' ' 99' ' ' ILE . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' A' ' 64' ' ' VAL . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 83' ' ' LYS . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t . . . . . 0 C--O 1.23 0.056 0 CA-C-O 120.708 0.289 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.731 ' CB ' HG21 ' A' ' 63' ' ' THR . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.666 ' HE2' HG21 ' A' ' 97' ' ' VAL . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 35' ' ' ILE . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 83' ' ' LYS . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 86' ' ' VAL . 1.6 mm? . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.718 0.294 . . . . 0.0 110.795 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 50' ' ' VAL . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.495 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' HG21 ' A' ' 56' ' ' THR . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 53' ' ' PHE . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CB ' ' A' ' 23' ' ' VAL . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' O ' HD11 ' A' ' 78' ' ' ILE . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.76 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.481 HD22 HG12 ' A' ' 73' ' ' VAL . 16.2 p30 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.572 HG21 HG23 ' A' ' 73' ' ' VAL . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.497 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.557 ' HD2' HG23 ' B' ' 123' ' ' VAL . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.567 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.892 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.76 ' CD1' HG11 ' A' ' 73' ' ' VAL . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.519 ' NE2' HG22 ' B' ' 125' ' ' ILE . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 89' ' ' MET . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 ' HE2' ' A' ' 27' ' ' LYS . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.504 ' C ' HD12 ' A' ' 99' ' ' ILE . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.557 HG23 ' HD2' ' A' ' 83' ' ' LYS . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.519 HG22 ' NE2' ' A' ' 91' ' ' GLN . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.733 0.301 . . . . 0.0 111.218 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.751 HD21 HG21 ' A' ' 63' ' ' THR . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' B' ' 125' ' ' ILE . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.645 HG23 ' HZ3' ' A' ' 27' ' ' LYS . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.518 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . . . . . . 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 86' ' ' VAL . 6.2 mp . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.785 0.326 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.471 ' H ' HG12 ' A' ' 50' ' ' VAL . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.751 HG21 HD21 ' A' ' 25' ' ' LEU . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 63' ' ' THR . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.584 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' THR . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.618 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.477 ' HE2' HG11 ' A' ' 73' ' ' VAL . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.453 HG13 HG11 ' A' ' 97' ' ' VAL . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.61 HG11 ' HE2' ' A' ' 27' ' ' LYS . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.428 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.618 HG11 ' CB ' ' A' ' 87' ' ' ALA . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.445 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 17.0 t . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.467 0.175 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' VAL . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.824 HD12 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.806 ' HE2' HG21 ' A' ' 97' ' ' VAL . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 30' ' ' GLN . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 35' ' ' ILE . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.744 0.307 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 50' ' ' VAL . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 56' ' ' THR . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 53' ' ' PHE . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.582 ' O ' HD11 ' A' ' 78' ' ' ILE . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.513 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 90' ' ' ILE . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 84' ' ' VAL . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 47' ' ' LEU . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.85 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.829 HG21 HD13 ' B' ' 125' ' ' ILE . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HG3' HG22 ' B' ' 125' ' ' ILE . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 89' ' ' MET . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.806 HG21 ' HE2' ' A' ' 27' ' ' LYS . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.711 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.824 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 63' ' ' THR . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 123' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 124' ' ' LYS . . . . . 0.428 ' NZ ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 125' ' ' ILE . . . . . 0.829 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.649 HG22 ' HG ' ' A' ' 104' ' ' LEU . 7.5 p . . . . . 0 N--CA 1.46 0.06 0 CA-C-O 120.909 0.385 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.3 t -120.32 114.31 33.36 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.063 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -68.52 120.3 7.25 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.421 2.081 . . . . 0.0 112.318 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.3 144.43 12.52 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.485 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 3.1 ptpp? -132.72 133.6 43.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.787 0.327 . . . . 0.0 110.892 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.539 HG13 HD11 ' A' ' 25' ' ' LEU . 11.1 p -122.98 139.89 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.112 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.3 m -95.34 90.43 5.82 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.898 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.539 HD11 HG13 ' A' ' 23' ' ' VAL . 0.3 OUTLIER -97.64 134.38 40.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.891 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.4 mt-30 -84.05 145.8 28.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.446 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 44.1 mmtt -65.42 157.38 29.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.971 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -88.78 -169.14 2.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.821 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -69.17 -29.53 67.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.226 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.418 ' HG3' HD12 ' A' ' 32' ' ' LEU . 2.7 pt20 -99.02 29.73 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.937 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.28 46.22 7.51 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.341 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.455 HD22 ' HA ' ' B' ' 125' ' ' ILE . 56.1 mt -148.47 106.23 3.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.878 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 35' ' ' ILE . 15.2 pt -56.08 -28.77 25.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.226 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.53 79.97 1.19 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.85 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.846 HD11 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -163.43 131.02 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.812 0.339 . . . . 0.0 110.974 179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.7 p -93.16 155.9 17.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.952 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -137.33 180.0 3.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.003 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.4 122.63 1.12 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.479 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.594 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.0 170.05 42.58 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.526 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -127.58 -139.47 4.9 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.684 -0.769 . . . . 0.0 112.425 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -166.7 149.81 6.79 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.812 0.339 . . . . 0.0 111.107 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 59.08 25.25 13.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.971 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER 179.17 -46.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.714 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -127.59 60.61 45.36 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.837 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -71.94 -7.14 20.51 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.637 2.224 . . . . 0.0 112.673 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -76.31 100.73 5.22 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.742 0.306 . . . . 0.0 110.965 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.594 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.3 mm? -83.62 135.31 34.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.822 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -136.69 169.69 17.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.03 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 68' ' ' ASP . 14.4 mt -91.97 143.82 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.166 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG21 ' OG ' ' B' ' 122' ' ' SER . 21.4 t -99.89 -56.75 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.289 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -164.15 179.67 6.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.05 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.0 t -121.42 164.19 18.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.4 m-85 -110.73 154.11 24.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.591 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -72.45 153.04 41.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.089 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 43.0 m-80 64.29 24.92 13.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.528 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 50.8 p -110.22 147.2 35.79 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.612 -0.267 . . . . 0.0 110.711 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -57.63 -30.88 90.26 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.513 2.142 . . . . 0.0 112.054 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -72.17 -31.44 65.94 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.938 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -85.0 -51.45 6.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.114 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 77.9 mt -57.73 -36.74 72.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.857 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.23 -41.72 73.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.903 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 75.88 70.55 1.26 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.496 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.479 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -148.03 -63.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.812 0.339 . . . . 0.0 110.887 -179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.522 HG12 ' CD2' ' A' ' 101' ' ' TYR . 11.5 m -96.15 132.81 39.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.116 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -172.94 -167.06 0.4 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.519 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.91 145.34 30.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.183 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -32.79 6.15 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.475 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.528 ' HB2' HD12 ' A' ' 49' ' ' ILE . 3.6 m-20 -87.93 126.09 34.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.875 0.369 . . . . 0.0 110.807 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -91.47 120.97 32.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.887 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.593 ' O ' HD11 ' A' ' 78' ' ' ILE . 11.7 tt -76.98 141.68 15.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.071 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.437 HG22 ' OD1' ' A' ' 102' ' ' ASN . 3.5 t -150.29 28.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.02 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.76 155.29 12.63 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.588 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.787 HG11 ' CD1' ' A' ' 90' ' ' ILE . 30.9 t -153.5 115.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.846 0.355 . . . . 0.0 111.055 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.644 HD21 HG13 ' A' ' 97' ' ' VAL . 71.5 m-80 57.65 27.72 14.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.039 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.54 -28.24 16.4 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.548 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -69.93 165.56 21.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.846 0.355 . . . . 0.0 110.925 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -105.32 137.32 43.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.818 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.593 HD11 ' O ' ' A' ' 70' ' ' ILE . 1.4 pp -113.3 -17.35 8.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.465 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.7 mttt -60.97 84.03 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.896 0.379 . . . . 0.0 110.912 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 146.45 -27.8 1.66 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.43 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.1 mttt -71.16 175.05 5.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.882 0.372 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.617 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -96.14 167.25 11.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.79 179.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.587 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -56.88 -52.35 65.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.961 179.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.2 p -62.27 -32.8 56.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.992 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -67.14 -49.49 64.62 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.996 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 82' ' ' THR . 24.6 t -64.51 -43.4 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.04 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.521 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -56.91 -51.62 68.39 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.129 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.84 -30.4 71.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.712 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.8 ttm -59.9 -50.74 72.59 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.95 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.787 ' CD1' HG11 ' A' ' 73' ' ' VAL . 13.4 mm -66.32 -46.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.995 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -58.29 -30.25 66.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.93 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -73.6 -45.52 52.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.836 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 89' ' ' MET . 12.8 t -59.57 142.39 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.022 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -130.41 141.07 50.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.897 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 95.13 -144.35 17.15 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.383 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -68.08 97.13 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.888 0.375 . . . . 0.0 110.92 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.644 HG13 HD21 ' A' ' 74' ' ' ASN . 36.1 t -94.02 124.29 46.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.14 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.602 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.7 OUTLIER -97.91 143.63 28.31 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.833 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.602 HD13 ' O ' ' A' ' 98' ' ' THR . 6.2 mm -134.74 117.13 22.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.166 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -85.38 91.13 8.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.778 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.522 ' CD2' HG12 ' A' ' 64' ' ' VAL . 50.8 p90 -97.72 157.68 15.92 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.99 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.598 ' O ' HD12 ' A' ' 104' ' ' LEU . 11.3 m120 -120.24 117.86 28.96 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.782 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.99 124.55 24.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.896 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.649 ' HG ' HG22 ' A' ' 18' ' ' THR . 1.9 mp . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.799 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.868 0.366 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.592 ' OG ' HG21 ' A' ' 50' ' ' VAL . 6.8 m -149.67 105.8 3.48 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.587 HG23 ' HD2' ' A' ' 83' ' ' LYS . 33.7 t -69.91 120.33 17.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.121 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -98.04 130.65 44.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.607 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.23 -0.89 . . . . 0.0 111.146 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.587 HG22 ' HG ' ' A' ' 104' ' ' LEU . 61.8 p . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.848 0.356 . . . . 0.0 110.819 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.0 t -125.0 90.99 50.17 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.107 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.11 88.29 0.38 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.53 2.153 . . . . 0.0 112.231 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.46 134.47 11.73 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.456 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -115.48 125.04 52.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.913 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.616 ' HB ' HG21 ' A' ' 63' ' ' THR . 9.7 p -109.01 145.91 15.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.007 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 3.5 m -105.14 89.33 3.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.887 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.2 mt -96.72 137.15 36.23 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.796 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.518 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -81.21 172.37 13.73 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.968 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.828 ' HE2' HG21 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -87.73 151.35 22.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.813 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -89.0 -169.43 2.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.9 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.15 -34.37 76.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.081 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -95.15 18.96 11.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.18 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.0 t30 58.02 30.22 18.91 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.816 0.341 . . . . 0.0 110.665 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.472 HD22 ' HA ' ' B' ' 125' ' ' ILE . 13.7 mt -131.91 113.67 13.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.938 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 35' ' ' ILE . 16.7 pt -58.74 -21.7 19.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.181 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.731 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 82.55 85.26 0.8 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.8 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.731 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.9 OUTLIER -166.58 120.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.773 0.321 . . . . 0.0 110.775 179.646 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.8 t -86.34 150.32 24.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.797 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -139.05 179.42 3.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.194 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -169.66 117.4 0.71 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.381 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.507 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -166.6 170.0 40.91 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.489 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -144.24 -138.09 3.3 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.605 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.24 40.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.8 0.333 . . . . 0.0 111.027 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.3 mm-40 65.85 -76.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.944 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -68.56 -35.78 77.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.868 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -145.45 64.89 11.07 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.986 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.58 -40.74 62.96 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.567 2.178 . . . . 0.0 112.227 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.1 m -61.64 133.59 55.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.507 HD13 ' HA3' ' A' ' 39' ' ' GLY . 1.5 mm? -96.86 131.52 43.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.785 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -110.36 160.26 16.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.043 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.625 HD11 ' HB ' ' A' ' 70' ' ' ILE . 35.4 mt -109.7 128.14 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.032 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG12 ' H ' ' A' ' 51' ' ' GLN . 3.3 t -91.49 166.17 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.742 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.484 ' H ' HG12 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -45.38 146.59 0.95 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.887 0.375 . . . . 0.0 111.567 -179.799 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.2 t -88.19 164.63 2.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.281 179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' N ' HG12 ' A' ' 52' ' ' VAL . 19.4 m-85 -97.85 151.49 20.17 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.441 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -75.2 154.48 37.58 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.055 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m120 70.08 19.79 6.66 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.476 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 69.2 p -107.11 152.75 41.18 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-O 120.618 0.247 . . . . 0.0 110.711 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.3 -25.88 81.29 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.436 2.09 . . . . 0.0 111.97 179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -79.51 -31.9 42.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.882 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -88.23 -28.39 21.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.061 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.7 mt -79.14 -38.71 35.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.82 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -68.15 -51.77 42.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.41 79.74 1.28 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.486 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.616 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.2 OUTLIER -157.5 -55.86 0.08 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.598 HG13 HG11 ' A' ' 23' ' ' VAL . 27.3 m -102.82 142.58 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.146 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -173.72 -177.69 1.46 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.132 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -60.14 148.18 37.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.032 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.25 -32.8 7.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.492 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -76.09 156.89 33.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.782 0.325 . . . . 0.0 110.857 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 12.8 tm-20 -108.95 102.92 11.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.901 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.625 ' HB ' HD11 ' A' ' 49' ' ' ILE . 16.0 tt -70.07 147.6 11.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.8 t -165.7 37.01 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.01 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.39 151.49 6.67 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.642 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.828 HG11 ' CD1' ' A' ' 90' ' ' ILE . 32.9 t -153.8 113.05 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.803 0.335 . . . . 0.0 110.942 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.771 ' OD1' HG13 ' A' ' 97' ' ' VAL . 9.2 m120 61.02 27.71 17.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.97 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.79 -28.92 13.33 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.656 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.35 144.7 44.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.818 0.342 . . . . 0.0 110.876 -179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -84.73 150.66 24.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.923 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.512 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.6 pp -133.22 11.99 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.566 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -68.72 -31.23 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.827 0.346 . . . . 0.0 110.79 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.43 30.17 10.3 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.431 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmmt -123.29 160.78 25.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.722 0.296 . . . . 0.0 110.885 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.806 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.6 OUTLIER -98.85 176.11 5.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.886 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.482 ' HD2' HG23 ' B' ' 123' ' ' VAL . 6.4 pttm -60.31 -32.7 71.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.901 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.0 m -73.56 -37.52 50.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.036 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -69.5 -50.89 40.98 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.716 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.806 HG22 ' O ' ' A' ' 82' ' ' THR . 4.0 m -62.39 -36.31 74.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.108 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -62.77 -50.14 72.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.982 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.41 -32.21 73.73 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.783 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.69 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.7 ttp -60.11 -55.57 32.25 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.867 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.828 ' CD1' HG11 ' A' ' 73' ' ' VAL . 39.9 mm -59.17 -48.88 85.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.047 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -59.82 -27.37 66.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.881 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -78.21 -41.21 35.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.69 HG23 ' O ' ' A' ' 89' ' ' MET . 29.2 t -58.8 144.86 11.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.114 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.17 152.73 48.43 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.88 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.44 -140.15 25.82 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.451 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -72.81 114.84 11.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.871 0.367 . . . . 0.0 110.821 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.828 HG21 ' HE2' ' A' ' 27' ' ' LYS . 24.9 t -106.97 137.8 36.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.193 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 33.3 m -109.16 138.98 44.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.892 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.578 HD13 HG13 ' A' ' 73' ' ' VAL . 13.3 mm -126.6 123.21 62.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.078 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -95.39 101.81 13.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.799 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.494 ' CD1' HG12 ' A' ' 64' ' ' VAL . 52.6 p90 -115.23 154.62 28.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.676 ' O ' HD12 ' A' ' 104' ' ' LEU . 54.8 m-80 -114.88 121.61 43.74 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.921 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.5 135.71 38.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.941 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 102' ' ' ASN . 4.6 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 . . . . . 0 N--CA 1.457 -0.119 0 CA-C-O 120.819 0.342 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 1.3 p -81.16 169.28 17.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.976 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.482 HG23 ' HD2' ' A' ' 83' ' ' LYS . 30.1 t -124.8 133.23 69.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.018 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.441 ' CG ' ' CE1' ' A' ' 53' ' ' PHE . 0.6 OUTLIER -100.61 121.42 41.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.065 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.526 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.104 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.406 HG22 ' HA ' ' A' ' 104' ' ' LEU . 2.1 p . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.905 0.384 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.602 ' O ' HG13 ' A' ' 19' ' ' VAL . 9.6 p -121.87 107.74 35.46 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.979 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -68.93 151.72 73.63 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.461 2.108 . . . . 0.0 112.374 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -167.02 153.7 23.54 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.466 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -135.33 129.57 33.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.858 0.361 . . . . 0.0 110.832 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.678 ' HB ' HG21 ' A' ' 63' ' ' THR . 12.0 p -115.69 133.19 62.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.06 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 96' ' ' GLU . 19.9 m -91.98 93.62 8.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.833 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 58' ' ' ALA . 3.0 mt -92.64 167.01 12.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.7 mp0 -115.8 123.94 49.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.884 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.746 ' HE2' HG11 ' A' ' 97' ' ' VAL . 9.5 mmtm -61.19 156.44 18.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 56.5 p30 -90.78 -172.57 3.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.906 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.41 -29.27 65.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.364 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -97.5 26.42 4.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.141 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 43.6 31.13 0.41 Allowed 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.396 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 9.5 mt -128.48 101.64 6.27 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.935 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 35' ' ' ILE . 8.2 pt -54.59 -28.0 18.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.199 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.549 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.79 75.35 1.29 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.845 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.609 HD11 HD11 ' A' ' 33' ' ' ILE . 4.2 pt -159.49 129.43 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.797 0.332 . . . . 0.0 111.116 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.3 t -93.2 137.96 32.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.818 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -132.84 146.79 32.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.259 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.57 149.61 19.52 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -69.86 165.22 50.89 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.598 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -156.25 93.91 0.14 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.647 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -153.63 -54.15 0.11 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.876 0.369 . . . . 0.0 111.112 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -96.94 -55.63 2.81 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.816 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.0 m-85 -99.19 29.22 4.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.776 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -179.44 127.48 0.25 Allowed Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.496 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.73 -11.76 26.14 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.343 2.029 . . . . 0.0 112.902 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 5.8 p -155.54 164.75 38.25 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.934 0.397 . . . . 0.0 111.125 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD22 HG21 ' A' ' 86' ' ' VAL . 1.1 tp -69.96 170.07 12.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.789 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -152.06 169.3 22.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.906 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.737 HD12 ' HB2' ' A' ' 68' ' ' ASP . 27.4 mt -110.28 158.87 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.033 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -115.91 -64.17 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.301 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -168.65 -178.86 3.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.089 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -116.31 164.6 12.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.983 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 17.8 m-85 -104.61 153.29 21.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.627 179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -75.07 150.62 38.82 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.116 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.7 m-80 61.26 27.05 16.82 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.399 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 43.9 p -111.75 152.36 44.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.675 179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.17 -32.66 96.24 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.631 2.221 . . . . 0.0 112.214 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.604 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -69.08 -40.19 78.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.21 179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -78.35 -49.3 13.85 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.101 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.0 mt -56.64 -35.37 68.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.982 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -66.98 -55.59 13.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.821 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.66 77.55 1.36 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.569 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.678 HG21 ' HB ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -158.09 -66.48 0.09 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.766 0.317 . . . . 0.0 110.948 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 28.3 m -87.4 140.02 16.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.21 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.69 -169.01 0.4 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.543 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -59.1 137.79 57.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.21 -41.81 2.04 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.589 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.737 ' HB2' HD12 ' A' ' 49' ' ' ILE . 93.8 m-20 -59.77 155.04 16.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.802 0.334 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -117.52 105.81 12.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.885 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.5 tt -70.28 146.65 12.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.078 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.433 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.2 t -167.44 33.09 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.969 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.17 156.11 11.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.569 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.781 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -157.53 120.28 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.842 0.353 . . . . 0.0 111.019 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 58.63 30.47 19.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.4 -31.51 7.38 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.508 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -64.23 156.99 27.04 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.809 0.337 . . . . 0.0 110.884 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.8 t -107.4 124.04 49.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.928 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.529 HG21 HG13 ' A' ' 86' ' ' VAL . 2.1 pp -104.74 17.31 5.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.445 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mttt -64.05 82.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.861 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.51 -27.71 3.35 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.51 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.425 ' HB3' HG23 ' A' ' 86' ' ' VAL . 6.6 mmtt -59.45 148.84 31.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.35 . . . . 0.0 110.995 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.38 169.49 15.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.843 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -57.25 -40.9 78.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.045 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 85' ' ' GLU . 27.0 m -68.77 -40.67 81.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.194 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.412 ' N ' HG23 ' A' ' 84' ' ' VAL . 14.8 mm-40 -65.87 -60.95 2.36 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.934 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.863 HG21 HD22 ' A' ' 47' ' ' LEU . 43.1 t -56.51 -48.6 80.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.226 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -52.14 -44.73 64.68 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.231 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 12.5 mttt -63.08 -37.01 85.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.771 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 1.8 ttp -61.72 -38.12 86.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.797 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.955 HG21 HD13 ' B' ' 125' ' ' ILE . 25.6 mm -68.51 -56.04 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.034 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -57.02 -28.36 62.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.962 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -75.22 -53.61 8.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.956 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.413 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.1 p -61.38 137.97 22.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.088 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -123.15 161.64 24.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.863 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 84.83 -163.74 38.55 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.492 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.458 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.0 OUTLIER -64.43 102.68 0.57 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.872 0.368 . . . . 0.0 110.923 -179.976 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.746 HG11 ' HE2' ' A' ' 27' ' ' LYS . 26.1 m -94.77 142.71 13.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.055 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.06 101.55 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.494 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.5 mp -90.64 124.02 43.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.981 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -86.56 108.09 18.42 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.401 ' CZ ' HG22 ' A' ' 63' ' ' THR . 21.3 p90 -116.79 147.74 41.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.944 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -115.53 122.35 45.43 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.754 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -81.82 125.52 30.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.797 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.406 ' HA ' HG22 ' A' ' 18' ' ' THR . 9.4 mp . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.145 0 CA-C-O 120.913 0.387 . . . . 0.0 110.939 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.37 154.47 18.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.947 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 26.0 t -115.45 128.54 72.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.076 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.83 125.88 37.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.815 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.955 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.94 HG22 HD11 ' A' ' 104' ' ' LEU . 4.9 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.911 0.386 . . . . 0.0 110.937 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -117.67 97.45 50.77 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.108 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.65 116.71 4.4 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.454 2.103 . . . . 0.0 112.397 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -147.39 135.64 5.72 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 11.7 pttt -111.49 123.95 51.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.811 0.338 . . . . 0.0 110.93 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.726 ' CG2' HG21 ' A' ' 63' ' ' THR . 10.4 p -114.21 137.19 48.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.12 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.0 m -99.6 90.91 4.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.962 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.536 HD12 HD13 ' A' ' 99' ' ' ILE . 7.3 mt -85.01 161.22 19.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -109.29 123.32 49.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.939 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.784 ' HD3' HG23 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -61.25 143.14 56.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.828 -179.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -73.4 -172.91 1.25 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.24 70.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.222 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.8 30.25 3.42 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.999 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 43.83 36.96 1.47 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.45 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 30.1 mt -130.05 99.93 5.25 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.931 -179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.784 HG23 ' HD3' ' A' ' 27' ' ' LYS . 21.8 pt -61.12 -36.47 72.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' O ' HG13 ' A' ' 52' ' ' VAL . . . 97.23 79.12 1.44 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.787 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.515 HD11 HD11 ' A' ' 33' ' ' ILE . 13.9 pt -159.09 137.09 2.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.783 0.325 . . . . 0.0 111.027 179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.0 t -104.97 137.24 43.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.73 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.508 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.7 pp -131.19 165.23 32.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.92 0.391 . . . . 0.0 111.256 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -146.05 137.28 6.81 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.295 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.494 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -162.13 156.8 28.5 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.572 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 44' ' ' CYS . . . -169.95 88.82 0.09 OUTLIER Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.408 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -45.04 -29.42 0.86 Allowed 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.24 -32.56 16.97 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.988 0.423 . . . . 0.0 111.004 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -161.21 29.03 0.14 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.63 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.429 ' N ' ' O ' ' A' ' 40' ' ' GLY . 0.7 OUTLIER 172.56 75.11 0.04 OUTLIER Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.483 -179.715 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.78 -14.32 44.07 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.457 2.104 . . . . 0.0 112.591 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 7.6 m -82.64 135.4 35.05 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.997 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.766 ' HG ' HG21 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -90.59 151.12 21.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.758 179.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' CD1' ' HG3' ' A' ' 69' ' ' GLU . 63.9 m-85 -149.47 153.57 37.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 111.106 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.654 HD12 ' HB2' ' A' ' 68' ' ' ASP . 19.3 mt -84.52 161.38 3.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.858 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.2 t -118.39 -68.14 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.706 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 12.1 tt0 -162.76 150.48 13.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.832 0.348 . . . . 0.0 111.222 -179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.613 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.4 t -101.49 157.92 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.789 179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.459 ' O ' HG23 ' A' ' 56' ' ' THR . 52.4 m-85 -105.38 146.06 29.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.541 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -62.19 158.28 17.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.446 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 64.15 20.14 12.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.937 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 53' ' ' PHE . 71.3 p -104.31 146.95 33.56 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.661 0.267 . . . . 0.0 110.51 179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -56.72 -29.9 82.08 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.455 2.103 . . . . 0.0 111.99 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.19 -31.71 62.77 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.099 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.74 -28.09 19.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.4 mt -74.3 -36.56 63.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.671 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -76.28 -34.47 59.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.811 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.2 90.72 0.13 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.535 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.726 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.7 m -162.98 -66.24 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.723 0.297 . . . . 0.0 110.963 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 23' ' ' VAL . 29.2 m -95.44 137.91 22.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.147 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.402 ' HA ' ' CG2' ' A' ' 52' ' ' VAL . . . -170.56 -171.48 1.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.2 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.63 142.45 33.78 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.251 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 94.94 -28.67 10.86 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.396 -179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.654 ' HB2' HD12 ' A' ' 49' ' ' ILE . 7.5 m-20 -73.48 143.65 46.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.754 0.311 . . . . 0.0 110.786 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.423 ' HG3' ' CD1' ' A' ' 48' ' ' TYR . 55.8 tt0 -103.96 104.41 14.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.939 -180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.401 HD12 HG21 ' A' ' 99' ' ' ILE . 13.7 tt -71.13 145.08 12.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.5 t -163.93 38.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.962 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 173.0 156.57 13.06 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.651 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.799 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -164.97 116.04 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.935 0.398 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 60.23 27.6 17.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.9 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.62 -27.49 15.65 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.652 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.54 163.1 28.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.806 0.336 . . . . 0.0 110.948 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.5 t -100.22 136.18 40.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.853 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CE ' ' A' ' 89' ' ' MET . 2.2 pp -115.45 -12.43 11.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.615 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -28.78 25.32 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.804 0.335 . . . . 0.0 111.097 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -102.16 33.4 6.55 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.483 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.8 mttt -132.79 168.47 18.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.864 0.364 . . . . 0.0 110.87 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.506 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -101.06 174.89 5.8 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.817 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.7 pttp -58.54 -40.21 82.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.965 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.7 m -69.19 -35.52 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.141 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -69.85 -54.52 13.13 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.766 HG21 ' HG ' ' A' ' 47' ' ' LEU . 23.1 t -60.13 -44.08 94.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.062 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -57.12 -48.7 78.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.165 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -31.11 72.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.955 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.458 ' CE ' HG22 ' A' ' 78' ' ' ILE . 0.4 OUTLIER -63.11 -47.54 82.39 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.864 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.799 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.2 mm -67.85 -35.55 72.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.019 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.0 -27.08 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.87 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 -80.9 -50.11 10.18 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.937 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -58.87 154.0 3.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.171 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.402 ' N ' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -135.07 168.49 19.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 71.73 -149.0 44.22 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.545 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.71 122.37 24.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.795 0.331 . . . . 0.0 110.894 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 13.6 m -108.32 147.49 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.045 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.7 m -117.16 104.52 11.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.895 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.536 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -99.61 129.64 49.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.089 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -93.6 104.36 16.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.797 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.421 ' CE1' HG22 ' A' ' 63' ' ' THR . 45.2 p90 -108.27 169.44 8.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.008 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -134.59 116.19 14.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.684 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.97 132.27 45.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.892 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.94 HD11 HG22 ' A' ' 18' ' ' THR . 3.7 mm? . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.864 0.364 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 3.9 p -123.23 149.62 44.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.837 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.0 t -108.26 135.02 48.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.078 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.66 137.22 42.81 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.929 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.682 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.254 -0.879 . . . . 0.0 111.135 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 27.9 p . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.684 0.278 . . . . 0.0 110.713 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -118.1 81.06 15.87 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.261 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -61.67 128.33 24.26 Favored 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.564 2.176 . . . . 0.0 112.056 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -149.87 124.88 1.85 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.68 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.53 112.69 24.93 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.857 0.361 . . . . 0.0 110.707 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.658 HG21 HG21 ' A' ' 63' ' ' THR . 13.3 p -104.4 141.46 19.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.22 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -108.64 87.87 2.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.846 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 63' ' ' THR . 2.9 mt -96.6 139.25 32.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.889 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.33 163.51 21.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.807 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.691 ' HE2' HG21 ' A' ' 97' ' ' VAL . 3.1 mmtm -77.76 129.88 36.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.901 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -65.06 -172.67 0.09 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.982 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.73 -30.74 71.66 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.191 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.502 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.8 pt20 -98.77 30.6 3.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.878 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 4.5 p-10 45.12 38.18 3.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.399 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.502 HD12 ' HG3' ' A' ' 30' ' ' GLN . 13.5 mt -144.29 109.5 5.09 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.044 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.437 HD11 HD11 ' A' ' 35' ' ' ILE . 6.5 pt -53.57 -26.83 13.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 69.72 1.31 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.948 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.613 HG22 ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -148.81 122.09 1.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.808 0.337 . . . . 0.0 110.796 179.469 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.3 t -88.4 156.97 18.84 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.662 179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.4 HG22 ' HA ' ' A' ' 49' ' ' ILE . 20.3 pt -147.33 176.24 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.135 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -168.89 129.82 1.95 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.483 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.79 167.85 40.86 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.465 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -116.59 -130.86 4.59 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.449 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -175.8 -58.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.807 0.337 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -75.24 -30.32 60.5 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.99 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -115.46 -38.91 3.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.06 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -131.64 87.54 45.56 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.936 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -70.96 -27.6 20.55 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.601 2.2 . . . . 0.0 112.309 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 36.0 t -68.71 134.36 49.72 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.035 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -104.17 135.39 45.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.845 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.6 m-85 -121.08 160.63 23.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.952 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.4 ' HA ' HG22 ' A' ' 37' ' ' ILE . 35.8 mt -103.31 132.89 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.052 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.498 HG12 ' N ' ' A' ' 51' ' ' GLN . 14.4 t -98.83 161.79 2.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.969 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.616 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 11.6 pt20 -46.31 133.01 9.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.315 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.671 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 30.3 m -79.62 -177.33 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.021 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.444 ' O ' HG23 ' A' ' 56' ' ' THR . 48.8 m-85 -111.45 146.33 37.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.601 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -61.49 162.56 7.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.082 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 m-80 64.22 18.24 11.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.812 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 53' ' ' PHE . 48.0 p -107.54 149.41 38.83 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 120.613 0.244 . . . . 0.0 110.74 179.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.06 -27.85 85.78 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.629 2.219 . . . . 0.0 112.142 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.407 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -82.19 -32.8 29.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.114 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.671 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.38 -28.97 26.6 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.135 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.2 mt -81.58 -43.48 18.62 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.818 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 10.5 m-20 -67.31 -30.45 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.68 66.12 2.4 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.504 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.658 HG21 HG21 ' A' ' 23' ' ' VAL . 12.4 t -131.53 -46.21 0.98 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.864 0.364 . . . . 0.0 110.946 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.47 HG22 HG23 ' A' ' 63' ' ' THR . 12.8 m -121.67 141.05 43.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.198 -179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.79 -170.74 0.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.025 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.616 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -64.65 106.89 1.27 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 145.82 -29.53 1.7 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.391 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 30.7 m-20 -88.13 162.77 16.55 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.808 0.337 . . . . 0.0 110.88 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -119.5 106.77 12.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.963 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.9 tt -70.0 144.65 13.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.11 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.567 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.0 t -158.63 32.32 0.23 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.02 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.28 147.28 5.7 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.577 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.725 HG11 HD13 ' A' ' 90' ' ' ILE . 23.1 t -148.02 109.88 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.743 0.306 . . . . 0.0 111.006 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 61.61 28.53 17.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.996 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.35 -27.34 19.9 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.657 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.65 158.62 31.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.905 0.383 . . . . 0.0 110.831 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.4 m -101.1 120.85 40.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.822 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.567 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.2 pp -99.29 -11.8 8.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.568 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.34 -28.74 30.33 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.756 0.312 . . . . 0.0 111.125 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -107.38 36.51 4.35 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.486 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 2.7 mtmt -139.83 155.41 47.26 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.82 0.343 . . . . 0.0 110.977 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.492 ' CG2' ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -84.67 172.41 11.57 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.979 179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -63.06 -31.48 72.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG13 ' N ' ' A' ' 85' ' ' GLU . 12.0 p -71.97 -43.11 68.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.093 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 84' ' ' VAL . 16.9 mm-40 -66.01 -49.92 66.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.881 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 82' ' ' THR . 30.2 m -59.54 -43.63 91.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.095 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.45 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -56.88 -50.08 73.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.188 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.61 -31.96 72.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.836 179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.811 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.7 ttp -62.9 -45.65 91.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.773 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.725 HD13 HG11 ' A' ' 73' ' ' VAL . 29.2 mm -64.18 -49.25 82.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.039 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -59.23 -28.87 67.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.928 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -74.52 -44.34 51.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.91 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' O ' ' A' ' 89' ' ' MET . 14.9 t -59.66 142.18 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.009 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.95 152.19 48.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 81.6 -142.88 23.11 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.403 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.28 103.45 2.84 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.85 0.357 . . . . 0.0 110.921 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.691 HG21 ' HE2' ' A' ' 27' ' ' LYS . 28.4 t -93.48 132.94 36.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.005 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.6 m -112.68 132.03 55.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.085 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.484 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.6 mp -131.19 130.4 63.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.971 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.7 m-70 -93.78 101.56 13.67 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.855 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 34.0 p90 -112.79 149.31 33.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.871 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 m-80 -118.25 110.69 17.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.705 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.431 ' O ' HD23 ' A' ' 104' ' ' LEU . 6.6 mttt -71.2 146.22 49.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.867 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.431 HD23 ' O ' ' A' ' 103' ' ' LYS . 3.1 mt . . . . . 0 C--N 1.329 -0.314 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.773 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.735 0.302 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.2 p -128.3 134.93 49.01 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.886 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.5 t -104.11 128.95 57.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.105 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.14 127.12 42.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.84 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.695 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.167 -0.92 . . . . 0.0 111.16 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.884 0.373 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.92 95.0 5.0 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.11 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -68.84 99.34 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.531 2.154 . . . . 0.0 112.227 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.11 137.98 11.4 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.437 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.91 103.01 11.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.833 0.349 . . . . 0.0 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.737 HG21 HG21 ' A' ' 63' ' ' THR . 11.3 p -88.64 152.51 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.004 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.4 HG23 ' OG1' ' A' ' 98' ' ' THR . 5.8 m -119.04 101.83 8.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.92 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.705 HD22 ' HA ' ' A' ' 58' ' ' ALA . 0.5 OUTLIER -108.78 138.87 44.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.885 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -86.74 145.79 26.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.916 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.866 ' NZ ' HG23 ' A' ' 33' ' ' ILE . 3.8 mmtm -59.94 150.59 28.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -84.5 -168.47 2.19 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.96 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.63 -31.77 72.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.047 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.15 34.54 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.7 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 44.29 47.29 7.84 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.402 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 17.1 mt -144.34 104.56 4.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.844 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.866 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 11.7 pt -57.24 -30.64 35.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.157 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.409 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 91.87 74.44 1.28 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.773 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.503 HD11 HD11 ' B' ' 125' ' ' ILE . 13.0 pt -157.29 143.44 9.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.804 0.335 . . . . 0.0 110.991 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -109.85 148.63 31.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.839 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.6 pt -141.23 172.69 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.126 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.51 130.76 2.61 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.543 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.475 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.06 165.34 38.67 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.582 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 82' ' ' THR . . . -102.15 -124.58 5.45 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.577 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.738 ' HB2' ' CG2' ' A' ' 82' ' ' THR . . . -160.76 -64.92 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 111.184 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 27.1 mm-40 -90.67 -61.81 1.59 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -68.42 -47.74 66.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.035 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.5 m -120.64 75.91 26.75 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -72.55 -11.69 26.47 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.583 2.189 . . . . 0.0 112.604 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.1 147.77 32.64 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.872 0.367 . . . . 0.0 110.953 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.475 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.0 mm? -115.48 154.42 29.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.719 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.12 145.4 26.3 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.117 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.77 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.7 mt -81.7 153.07 4.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.1 t -103.55 -64.94 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.353 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -165.33 179.88 5.96 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.091 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.481 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.6 t -117.86 164.92 13.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.016 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.662 ' HB2' HG21 ' A' ' 56' ' ' THR . 50.7 m-85 -109.0 156.03 20.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.604 179.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -75.98 151.32 37.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.074 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 62.32 26.37 15.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.538 179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.662 HG21 ' HB2' ' A' ' 53' ' ' PHE . 73.0 p -109.66 150.98 41.99 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.49 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.48 -36.17 97.77 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.497 2.131 . . . . 0.0 112.173 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.705 ' HA ' HD22 ' A' ' 25' ' ' LEU . . . -67.3 -33.39 75.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.138 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.77 -50.42 8.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.176 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 68.1 mt -55.88 -33.18 64.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.043 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -83.45 -30.96 26.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.879 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.32 94.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.555 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.737 HG21 HG21 ' A' ' 23' ' ' VAL . 13.5 t -157.24 -45.75 0.07 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.845 0.355 . . . . 0.0 111.023 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG22 HG23 ' A' ' 63' ' ' THR . 12.9 m -122.31 141.15 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.23 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.414 ' CB ' HG23 ' A' ' 52' ' ' VAL . . . -174.68 -166.91 0.27 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.095 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.52 106.17 0.27 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.191 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 133.48 -40.81 1.55 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.382 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.77 ' HB2' HD12 ' A' ' 49' ' ' ILE . 23.5 m-20 -67.29 145.04 55.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.852 0.358 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 57.0 tt0 -108.82 107.13 17.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.972 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.455 ' O ' HD11 ' A' ' 78' ' ' ILE . 18.6 tt -75.12 127.22 36.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.073 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 6.7 t -141.93 32.65 1.58 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.021 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.52 170.49 39.91 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.481 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.815 HG21 ' CD1' ' A' ' 90' ' ' ILE . 12.6 p -174.66 132.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 120.811 0.338 . . . . 0.0 111.144 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 54.82 22.54 4.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.428 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.49 -34.99 5.28 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.95 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.623 ' HE ' HG13 ' A' ' 73' ' ' VAL . 0.2 OUTLIER -84.69 148.48 26.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.813 0.339 . . . . 0.0 111.066 -179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 61.2 p -76.86 165.1 25.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.455 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.7 pp -132.42 9.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.575 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.2 mtpt -63.15 -30.62 71.73 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.784 0.326 . . . . 0.0 110.819 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.38 39.09 2.92 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.476 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.7 mttt -137.8 152.75 49.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.772 0.32 . . . . 0.0 110.924 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.854 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -81.38 172.99 12.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.81 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HD2' HG23 ' B' ' 123' ' ' VAL . 9.4 pttt -64.24 -33.59 76.16 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.922 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.9 p -71.88 -45.1 66.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.966 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' N ' HG13 ' A' ' 84' ' ' VAL . 67.3 mm-40 -61.37 -41.95 97.92 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.854 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.854 HG23 ' O ' ' A' ' 82' ' ' THR . 23.9 t -66.28 -50.6 66.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.053 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.623 ' HB1' ' CG2' ' B' ' 125' ' ' ILE . . . -56.22 -53.26 59.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.05 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 3.1 mttp -60.08 -31.36 69.94 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.821 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.758 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -61.89 -47.2 86.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.785 179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.815 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.9 mm -63.13 -51.47 71.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.989 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.496 HE21 HG22 ' B' ' 125' ' ' ILE . 24.9 mt-30 -57.08 -29.46 63.49 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.952 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -74.14 -38.68 63.68 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.831 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.758 HG23 ' O ' ' A' ' 89' ' ' MET . 18.7 t -61.04 152.94 5.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.059 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 mmtt -137.04 153.01 50.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.826 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.5 -140.55 20.51 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.441 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -82.6 96.6 8.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.705 HG21 ' HE2' ' A' ' 27' ' ' LYS . 29.1 t -79.32 154.7 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.032 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 ' N ' HG12 ' A' ' 97' ' ' VAL . 40.5 m -131.53 134.91 46.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.89 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 5.3 mp -130.56 133.83 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.988 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -98.67 100.11 11.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.845 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -103.3 167.32 9.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.913 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -126.22 117.65 23.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -78.63 120.55 23.47 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.869 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.0 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.148 0 CA-C-O 120.906 0.384 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.9 165.85 26.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.817 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.581 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -131.29 130.95 63.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.121 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.33 123.21 45.07 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.99 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.699 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.113 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 38.2 p . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.811 0.338 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.644 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.7 p -120.98 94.34 48.96 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.094 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.48 127.2 19.77 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.562 2.175 . . . . 0.0 112.357 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.98 132.97 5.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.447 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 0.2 OUTLIER -117.79 121.03 39.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.835 0.35 . . . . 0.0 110.887 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.689 HG11 HG13 ' A' ' 64' ' ' VAL . 11.5 p -108.5 134.55 50.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.126 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.438 ' OG1' HG23 ' A' ' 98' ' ' THR . 19.1 m -96.08 95.06 7.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.008 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 mt -105.47 148.32 27.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.902 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -94.99 159.18 15.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.815 ' NZ ' HG21 ' A' ' 97' ' ' VAL . 13.4 mmtm -76.83 154.46 33.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.828 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -83.32 -168.83 2.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.991 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.74 -33.26 75.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.05 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -99.03 26.05 6.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.775 179.902 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 53.24 29.54 8.61 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.789 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.433 HD12 ' HB2' ' A' ' 30' ' ' GLN . 13.1 mt -124.14 104.24 8.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.94 -179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 35' ' ' ILE . 12.9 pt -58.14 -28.54 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.103 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.617 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.22 83.69 1.03 Allowed Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.803 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.637 HD11 HD11 ' A' ' 33' ' ' ILE . 4.6 pt -162.0 123.65 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.746 0.308 . . . . 0.0 110.78 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.3 t -90.78 132.77 35.66 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.751 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.55 175.94 5.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.66 126.83 1.67 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.541 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.589 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.07 145.79 9.45 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.486 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.95 -121.75 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.518 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -168.86 -74.81 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.853 0.359 . . . . 0.0 111.198 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -85.55 -52.66 5.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.964 -179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -95.57 19.45 11.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.198 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 177.94 64.27 0.09 OUTLIER Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.888 0.375 . . . . 0.0 110.713 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -72.77 -9.1 23.42 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.561 2.174 . . . . 0.0 112.602 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 48' ' ' TYR . 67.2 m -69.35 127.99 34.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.816 0.341 . . . . 0.0 111.11 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.589 HD13 ' HA3' ' A' ' 39' ' ' GLY . 4.4 mm? -110.85 144.21 40.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.84 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.504 ' HA ' HG22 ' A' ' 70' ' ' ILE . 49.0 m-85 -150.46 146.2 26.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.135 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.3 mt -70.18 146.78 12.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.652 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG23 ' N ' ' A' ' 51' ' ' GLN . 27.1 m -114.8 -47.46 4.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.5 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -169.48 147.17 3.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 0.0 111.255 -179.619 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.471 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.2 t -102.34 164.82 3.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.893 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 37.2 m-85 -113.2 139.22 48.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.668 179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -59.31 162.1 4.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.281 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 68.16 12.21 8.67 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.876 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.463 HG23 ' O ' ' A' ' 53' ' ' PHE . 42.5 p -105.53 151.01 39.68 Favored Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.594 0.235 . . . . 0.0 110.6 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.22 -34.61 98.26 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.413 2.076 . . . . 0.0 112.039 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -68.69 -34.62 75.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.101 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.9 -52.45 6.69 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.198 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.8 mt -52.29 -41.75 63.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.166 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -65.48 -58.35 6.04 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.89 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 95.73 75.0 1.25 Allowed Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.468 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.714 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -153.46 -62.57 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.875 0.369 . . . . 0.0 110.983 179.959 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.689 HG13 HG11 ' A' ' 23' ' ' VAL . 31.0 m -96.35 120.72 46.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.07 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.14 -169.13 1.92 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.202 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.52 144.15 27.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.219 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.32 -29.04 10.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.478 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -76.13 163.78 26.75 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.629 ' HB2' HD11 ' A' ' 104' ' ' LEU . 0.0 OUTLIER -118.16 101.22 8.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.935 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.504 HG22 ' HA ' ' A' ' 48' ' ' TYR . 2.8 tt -69.96 136.2 26.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.87 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.536 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.1 t -163.29 42.26 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.984 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 167.25 137.25 2.19 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.572 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.8 t -141.66 115.46 4.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 59.48 29.59 19.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.021 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.25 -30.07 9.2 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.625 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.46 143.33 53.58 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.845 0.355 . . . . 0.0 110.885 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -88.7 127.01 35.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.808 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.536 HD11 ' HA ' ' A' ' 71' ' ' THR . 1.1 pp -100.88 2.05 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.628 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -64.07 82.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.902 0.382 . . . . 0.0 110.842 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.58 42.61 0.26 Allowed Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.505 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.0 mttt -136.29 154.02 51.0 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.831 0.348 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.521 HG23 ' HB2' ' A' ' 41' ' ' ALA . 23.7 m -81.58 163.7 22.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.783 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.429 ' N ' HG22 ' A' ' 82' ' ' THR . 19.8 pttm -57.58 -38.23 74.51 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.971 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 27.7 m -70.55 -36.15 64.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.975 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -67.92 -51.74 44.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.835 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 82' ' ' THR . 23.1 t -62.24 -52.25 62.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.063 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.82 -51.24 41.28 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.352 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -62.55 -31.95 72.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.765 179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 3.9 ttp -63.19 -36.78 84.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.917 HG21 HD13 ' B' ' 125' ' ' ILE . 15.2 mm -72.68 -56.06 11.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.028 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.627 ' NE2' HG22 ' B' ' 125' ' ' ILE . 45.2 mt-30 -54.38 -27.93 39.79 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.29 -179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -75.63 -54.9 6.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.928 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG12 ' O ' ' A' ' 90' ' ' ILE . 12.2 p -61.15 141.04 17.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -123.81 -174.61 3.02 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.85 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 67.55 -168.78 38.55 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -63.92 97.61 0.17 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.795 0.331 . . . . 0.0 110.93 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG21 ' NZ ' ' A' ' 27' ' ' LYS . 36.4 t -78.18 157.55 5.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.071 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.47 ' N ' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -135.22 105.05 6.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.985 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -96.0 121.77 46.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.037 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.412 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 26.5 m-70 -88.21 100.47 13.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.996 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.714 ' OH ' HG22 ' A' ' 63' ' ' THR . 42.8 p90 -107.98 160.38 15.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.969 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -121.45 119.67 32.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.413 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.0 mtmm -79.23 117.39 20.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.916 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.1 mp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.399 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.883 0.373 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 13.6 p -89.21 136.83 32.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.926 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.35 112.39 23.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.091 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.27 120.24 26.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.886 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.917 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.243 -0.885 . . . . 0.0 111.152 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.574 HG22 HD23 ' A' ' 104' ' ' LEU . 73.6 p . . . . . 0 C--O 1.23 0.042 0 CA-C-O 120.821 0.343 . . . . 0.0 110.907 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -121.8 91.42 48.67 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.107 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -68.65 121.06 7.95 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.564 2.176 . . . . 0.0 112.304 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -138.28 146.98 18.9 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.426 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.14 115.93 20.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.8 0.333 . . . . 0.0 111.016 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.739 ' CG2' HG21 ' A' ' 63' ' ' THR . 12.7 p -110.09 127.44 67.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.032 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.8 m -86.13 85.08 7.36 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.901 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.866 HD12 HD13 ' A' ' 99' ' ' ILE . 4.2 mt -82.51 170.15 15.55 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.752 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 13.6 mt-30 -118.45 148.68 42.32 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.861 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.504 ' HE2' HG22 ' A' ' 90' ' ' ILE . 18.5 mmtp -73.11 158.77 34.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.898 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -94.55 -172.49 2.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.46 70.01 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.804 ' HG3' HD12 ' A' ' 32' ' ' LEU . 3.4 pt20 -105.36 34.5 3.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.979 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.0 p-10 43.92 42.02 4.32 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.37 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.804 HD12 ' HG3' ' A' ' 30' ' ' GLN . 22.4 mt -141.84 106.14 4.81 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.923 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.488 HD11 HD11 ' A' ' 35' ' ' ILE . 23.5 pt -58.93 -35.49 56.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.043 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 95.32 86.73 1.72 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.849 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 6.7 pt -161.36 122.25 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.833 0.349 . . . . 0.0 110.96 179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.7 t -85.74 139.84 31.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.797 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.4 pp -134.94 172.9 15.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.212 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -161.09 121.68 1.05 Allowed Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.512 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -170.05 145.4 9.16 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.596 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.11 -134.31 4.06 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.478 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -152.84 -76.87 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.836 0.35 . . . . 0.0 111.144 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -76.29 -35.76 58.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.892 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -91.36 -31.13 16.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.4 m -151.91 79.86 6.24 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.944 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.65 -23.3 42.76 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.648 2.232 . . . . 0.0 112.338 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 14.1 m -70.41 128.8 37.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.993 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.5 mm? -101.5 148.78 24.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.71 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.432 ' CZ ' ' HG3' ' A' ' 69' ' ' GLU . 3.5 m-85 -140.31 153.88 46.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.068 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.904 HD12 ' HB2' ' A' ' 68' ' ' ASP . 8.0 mt -83.92 162.77 3.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.756 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.632 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.4 t -120.34 -68.72 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.632 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -163.63 147.58 10.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.911 0.386 . . . . 0.0 111.117 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.3 t -91.17 165.01 2.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.858 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.486 ' O ' HG23 ' A' ' 56' ' ' THR . 78.8 m-85 -115.74 139.24 50.34 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.943 0.402 . . . . 0.0 110.75 179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -59.64 158.88 9.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.8 m-80 68.91 13.91 8.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.843 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 53' ' ' PHE . 27.6 p -109.52 153.52 42.81 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 120.613 0.244 . . . . 0.0 110.581 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.49 -30.13 90.75 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.483 2.122 . . . . 0.0 111.954 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.47 -32.26 58.28 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.026 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.93 -24.34 21.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.241 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.2 mt -80.35 -36.42 34.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.812 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.27 -50.07 13.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.838 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.0 87.0 1.4 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.558 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.739 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.5 m -160.28 -66.64 0.07 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.778 0.323 . . . . 0.0 110.894 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 31.1 m -89.31 136.43 23.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.141 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.9 -167.88 0.25 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.116 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.632 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.43 145.12 33.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.172 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 85.86 27.09 32.7 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.601 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.904 ' HB2' HD12 ' A' ' 49' ' ' ILE . 11.8 m-20 -128.68 155.05 45.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.829 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.682 ' HB2' HD11 ' A' ' 104' ' ' LEU . 3.7 tm-20 -116.57 100.8 8.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.967 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.654 HD13 ' CG2' ' A' ' 99' ' ' ILE . 5.3 tp -69.89 126.95 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.932 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.525 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.4 t -149.01 34.94 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.06 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' O ' HD11 ' A' ' 70' ' ' ILE . . . 170.87 150.63 7.1 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.504 -0.855 . . . . 0.0 112.603 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.805 HG11 ' CD1' ' A' ' 90' ' ' ILE . 33.2 t -153.46 106.32 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.772 0.32 . . . . 0.0 111.012 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 61.34 28.83 18.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.934 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.51 -28.25 16.36 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.535 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.88 142.32 57.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.832 0.348 . . . . 0.0 110.881 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 3.5 m -91.61 123.54 35.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.925 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.644 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -110.4 16.84 7.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.514 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -30.39 70.9 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.818 0.342 . . . . 0.0 110.826 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -116.22 49.31 0.86 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.499 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.0 mmtt -134.89 152.74 52.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.787 0.327 . . . . 0.0 110.97 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 86' ' ' VAL . 2.7 m -84.42 168.43 15.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.785 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.408 ' H ' HG22 ' A' ' 82' ' ' THR . 0.3 OUTLIER -57.73 -34.31 69.37 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 -179.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.8 t -73.94 -38.25 49.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.98 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 65.7 mm-40 -64.57 -49.79 69.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 82' ' ' THR . 21.7 t -62.76 -43.53 98.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.985 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.503 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -58.6 -43.66 89.62 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.002 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.6 -35.46 79.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.943 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.697 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.9 ttp -58.99 -48.95 79.73 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.909 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.805 ' CD1' HG11 ' A' ' 73' ' ' VAL . 30.7 mm -63.61 -51.54 68.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.907 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -55.92 -26.06 45.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.053 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 27.3 mm-40 -78.22 -45.59 22.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.006 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.697 HG23 ' O ' ' A' ' 89' ' ' MET . 17.6 t -58.94 152.38 4.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.217 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.3 mmtt -137.79 149.88 46.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.878 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 83.84 -151.25 27.37 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.463 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.25 91.03 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.786 0.327 . . . . 0.0 110.902 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.495 HG11 ' HE3' ' A' ' 27' ' ' LYS . 10.2 p -84.16 139.97 16.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.085 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.656 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.5 m -108.53 139.9 42.62 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.942 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.866 HD13 HD12 ' A' ' 25' ' ' LEU . 3.9 mp -135.98 123.21 34.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.951 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -92.27 107.31 19.12 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.829 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -108.4 143.98 36.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -107.92 112.81 25.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.858 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tttt -70.09 129.84 40.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.878 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.682 HD11 ' HB2' ' A' ' 69' ' ' GLU . 1.6 mt . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.956 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.737 0.303 . . . . 0.0 110.823 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 17.2 m -146.26 119.91 9.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.963 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.503 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.4 t -69.02 130.24 33.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.125 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.3 122.46 45.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.867 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.596 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.246 -0.883 . . . . 0.0 111.13 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.475 HG22 ' HA ' ' A' ' 104' ' ' LEU . 66.3 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.817 0.341 . . . . 0.0 111.084 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.629 ' O ' HG13 ' A' ' 19' ' ' VAL . 7.3 p -136.22 97.84 11.79 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.67 160.97 1.47 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.473 2.115 . . . . 0.0 112.477 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.82 132.96 2.76 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.33 99.17 8.02 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.785 0.326 . . . . 0.0 110.999 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.691 HG21 HG21 ' A' ' 63' ' ' THR . 11.6 p -94.77 139.31 18.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.039 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 17.7 m -102.82 91.75 4.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.985 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.686 HD12 HD13 ' A' ' 99' ' ' ILE . 2.9 mt -90.78 170.07 10.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.707 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.725 ' O ' HG22 ' A' ' 33' ' ' ILE . 1.1 mp0 -118.69 162.69 18.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.892 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.534 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 4.0 mmtm -81.95 136.56 35.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.904 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -76.92 -175.82 3.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.848 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.39 -28.24 66.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.215 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.75 21.69 10.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.5 t30 54.32 36.45 25.3 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.881 0.372 . . . . 0.0 111.132 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.8 mt -144.39 115.38 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.725 HG22 ' O ' ' A' ' 26' ' ' GLN . 12.3 pt -59.96 -25.41 32.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.186 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.07 70.06 1.28 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.644 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.524 ' HA ' HG12 ' A' ' 52' ' ' VAL . 14.4 pt -147.12 144.79 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.818 0.342 . . . . 0.0 111.003 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.6 t -112.44 151.73 29.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.72 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.515 HD13 ' CD1' ' A' ' 47' ' ' LEU . 2.8 pp -144.07 159.17 15.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.143 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.54 118.94 0.94 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.481 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.76 169.58 42.18 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.508 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.22 -130.02 6.14 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.562 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -169.77 -42.21 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.754 0.311 . . . . 0.0 111.092 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -73.79 -45.7 49.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.002 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -114.77 -37.8 4.12 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.933 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -114.86 78.69 5.45 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.951 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.85 -42.04 1.84 Allowed 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.468 2.112 . . . . 0.0 112.307 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.9 m -63.22 107.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.013 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 37' ' ' ILE . 1.1 mm? -72.65 137.65 46.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.06 173.49 6.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.928 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.56 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -115.66 155.58 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.137 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.521 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.5 t -131.25 167.74 25.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.635 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 23.0 pt20 -45.21 133.97 6.61 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.466 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.557 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 26.8 m -85.83 -178.46 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.057 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.461 ' O ' HG23 ' A' ' 56' ' ' THR . 8.1 m-85 -107.77 142.88 37.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.71 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -61.04 159.06 12.26 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.184 -179.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 66.5 18.12 10.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.798 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 53' ' ' PHE . 40.8 p -108.58 149.67 39.7 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 120.681 0.277 . . . . 0.0 110.521 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.04 -30.06 88.89 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.486 2.124 . . . . 0.0 112.117 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.585 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -78.7 -32.27 46.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.286 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -85.36 -29.34 24.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.154 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.9 mt -79.66 -35.93 38.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.673 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -69.96 -53.0 19.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.83 43.76 3.79 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.467 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.691 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -117.93 -54.93 2.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.817 0.341 . . . . 0.0 110.956 179.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.585 HG23 ' HB1' ' A' ' 58' ' ' ALA . 30.7 m -106.88 131.56 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.147 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' HG13 ' A' ' 52' ' ' VAL . . . -175.48 -170.14 0.4 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.149 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.635 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.68 130.86 48.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.048 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.34 -30.83 7.33 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.439 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.56 ' HB2' HD12 ' A' ' 49' ' ' ILE . 79.4 m-20 -78.52 166.84 22.11 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.742 0.306 . . . . 0.0 110.83 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.23 101.2 6.4 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.868 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.3 tt -70.21 145.55 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.029 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.481 HG21 HD21 ' A' ' 102' ' ' ASN . 11.2 t -165.55 42.99 0.07 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.999 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 165.47 144.57 4.11 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.547 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.734 HG11 ' CD1' ' A' ' 90' ' ' ILE . 22.0 t -146.99 116.63 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 111.111 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 58.3 29.14 17.68 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.947 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.63 -32.02 6.95 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.564 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.3 132.98 48.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.901 0.381 . . . . 0.0 110.92 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.1 p -80.51 123.77 28.37 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.917 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.677 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -101.32 17.1 4.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.484 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -62.65 -32.47 73.52 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.957 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -108.64 46.18 1.21 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.482 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -137.21 149.56 47.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.832 0.349 . . . . 0.0 110.858 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.6 m -84.51 167.55 16.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.861 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.404 ' HD3' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.08 -31.8 65.61 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.978 179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.3 m -77.47 -35.26 21.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.909 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -68.48 -49.54 58.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.796 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 38.7 t -64.79 -45.21 95.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.971 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.432 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.79 -47.04 74.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.074 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.75 -35.81 82.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.75 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 2.0 ttp -59.84 -39.76 86.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.808 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.734 ' CD1' HG11 ' A' ' 73' ' ' VAL . 33.7 mm -74.07 -34.79 39.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.061 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -68.09 -26.38 65.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.012 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -84.98 -50.84 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.933 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.507 HG12 ' HA ' ' A' ' 90' ' ' ILE . 10.9 p -57.26 122.75 7.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.142 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.73 175.33 5.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.988 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 69.69 -152.83 51.92 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.484 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -69.44 96.03 0.86 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.87 0.366 . . . . 0.0 110.92 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 11.3 p -85.87 140.61 15.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.043 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.508 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.7 m -113.48 141.17 47.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.977 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.686 HD13 HD12 ' A' ' 25' ' ' LEU . 4.2 mp -137.48 136.84 46.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.105 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 15.7 m-70 -102.06 105.64 16.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.866 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -109.92 166.47 10.91 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.895 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.481 HD21 HG21 ' A' ' 71' ' ' THR . 40.4 m-20 -127.74 124.9 38.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.9 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -84.39 129.04 34.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.881 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.475 ' HA ' HG22 ' A' ' 18' ' ' THR . 1.7 mp . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.457 -0.096 0 CA-C-O 120.861 0.362 . . . . 0.0 110.834 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 15.9 m -161.59 151.45 16.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.884 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.432 HG11 ' CB ' ' A' ' 87' ' ' ALA . 30.5 t -108.49 123.14 63.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.129 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.429 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -92.73 122.62 35.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.803 179.945 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.58 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.149 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.513 HG22 HD23 ' A' ' 104' ' ' LEU . 3.8 p . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.906 0.384 . . . . 0.0 110.791 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.6 t -99.98 100.29 11.09 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -67.85 117.48 4.92 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.48 2.12 . . . . 0.0 112.261 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -141.51 115.98 1.05 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.488 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 8.0 pttp -108.96 139.36 43.93 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.953 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.58 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -129.28 137.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.074 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.9 m -99.18 90.58 4.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.845 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.1 mt -99.29 138.32 36.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -82.89 167.41 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.027 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.402 ' CE ' HG21 ' A' ' 97' ' ' VAL . 5.3 mmtp -80.82 158.59 25.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.943 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -94.62 -170.05 2.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.828 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.89 71.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.131 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.767 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.6 pt20 -100.31 30.69 3.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.959 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 43.9 39.26 2.55 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.452 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.767 HD12 ' HG3' ' A' ' 30' ' ' GLN . 9.4 mt -138.12 110.59 7.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.942 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 35' ' ' ILE . 17.7 pt -56.26 -30.15 29.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.229 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 86.91 80.45 1.2 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.847 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.781 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -163.59 131.52 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.775 0.321 . . . . 0.0 110.945 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 m -96.66 139.23 33.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.887 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.3 pt -131.42 167.4 26.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.065 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.26 135.73 4.32 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.45 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.96 168.68 41.58 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.541 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.41 -124.66 5.47 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.563 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB3' HE21 ' A' ' 42' ' ' GLN . . . -175.37 -42.03 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.791 0.329 . . . . 0.0 111.036 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.618 HE21 ' HB3' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -103.39 -47.2 4.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.85 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -94.33 -30.67 14.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -135.66 64.19 56.47 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.891 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -56.1 -28.63 70.98 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.531 2.154 . . . . 0.0 112.316 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.8 m -78.16 132.69 37.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.171 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.505 HD22 HG21 ' A' ' 86' ' ' VAL . 8.9 mp -99.74 169.92 8.92 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.794 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.537 ' HA ' HG22 ' A' ' 70' ' ' ILE . 41.0 p90 -160.83 158.31 28.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.758 HD13 ' CB ' ' A' ' 68' ' ' ASP . 3.6 mp -76.72 160.52 4.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.912 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.641 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.9 t -120.41 -69.3 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.564 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -156.39 145.42 20.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.928 0.394 . . . . 0.0 111.167 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.5 t -95.61 165.03 2.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.48 ' N ' HG12 ' A' ' 52' ' ' VAL . 31.0 m-85 -115.34 157.03 24.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.544 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -71.89 159.5 34.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.335 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 63.61 16.12 9.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.94 -0.573 . . . . 0.0 111.978 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 71.4 p -102.31 147.26 33.72 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 120.605 0.241 . . . . 0.0 110.494 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -58.21 -34.44 98.56 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.311 2.007 . . . . 0.0 112.016 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.81 -36.12 79.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.188 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.31 -48.9 10.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.16 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 67.3 mt -52.91 -42.25 65.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -77.09 -31.3 55.88 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.82 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 68.94 90.37 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.58 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -155.16 -56.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.772 0.32 . . . . 0.0 110.931 179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.408 HG12 ' CD2' ' A' ' 101' ' ' TYR . 13.7 m -103.34 138.47 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.147 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.61 -173.07 0.59 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.179 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.641 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -56.04 134.55 52.59 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.82 24.34 9.27 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.588 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.758 ' CB ' HD13 ' A' ' 49' ' ' ILE . 6.4 m-20 -129.88 162.48 28.48 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.814 0.34 . . . . 0.0 110.889 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -120.35 97.97 5.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.962 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.537 HG22 ' HA ' ' A' ' 48' ' ' TYR . 16.3 tt -72.5 130.38 35.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.902 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.7 t -147.53 30.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.06 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.96 165.68 33.23 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.607 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.926 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.2 p -165.18 134.48 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.885 0.374 . . . . 0.0 111.194 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 54.0 27.6 7.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.56 -27.58 15.23 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.55 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 55.7 mtt180 -74.99 -174.25 2.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.829 0.347 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -122.65 144.04 49.39 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.77 8.97 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.53 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -59.42 -28.22 66.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -112.89 36.37 4.13 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.487 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.4 mmtt -129.22 151.36 49.97 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.319 . . . . 0.0 110.934 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.476 HG23 ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -88.06 172.21 9.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.8 ttpt -57.73 -40.07 78.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.013 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -73.33 -34.15 42.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.09 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -68.4 -51.7 41.1 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.505 HG21 HD22 ' A' ' 47' ' ' LEU . 47.5 t -64.08 -48.12 87.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.998 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.14 -50.48 64.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.176 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.91 -31.22 72.33 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.719 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.469 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -61.47 -42.31 98.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.926 ' CD1' HG21 ' A' ' 73' ' ' VAL . 9.6 mm -73.0 -36.46 51.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.995 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.505 ' HG3' HG22 ' B' ' 125' ' ' ILE . 30.0 mt-30 -73.99 -28.41 61.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.025 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -83.19 -46.52 12.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.995 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 89' ' ' MET . 11.3 p -58.4 147.33 7.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.128 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 25.2 mmtt -122.02 -174.45 2.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.12 -140.18 48.17 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.496 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.8 pt-20 -75.1 124.89 27.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.893 0.377 . . . . 0.0 110.879 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG11 HG23 ' A' ' 90' ' ' ILE . 22.9 t -107.01 108.05 24.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.086 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.716 ' O ' HD13 ' A' ' 99' ' ' ILE . 4.6 m -84.44 155.32 22.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.946 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.716 HD13 ' O ' ' A' ' 98' ' ' THR . 24.2 mm -143.77 119.49 4.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.03 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -88.11 86.9 7.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.906 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.408 ' CD2' HG12 ' A' ' 64' ' ' VAL . 53.5 p90 -99.99 144.21 29.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -120.25 119.92 34.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.879 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.0 132.03 42.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.82 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.513 HD23 HG22 ' A' ' 18' ' ' THR . 4.8 mt . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.798 0.333 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.568 ' HB3' HG21 ' A' ' 50' ' ' VAL . 59.6 p -94.61 144.74 25.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -95.39 118.61 41.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.123 -179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.44 129.61 36.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.836 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.686 HD13 HG21 ' A' ' 90' ' ' ILE . 2.3 pp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.123 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.836 HG22 ' HG ' ' A' ' 104' ' ' LEU . 68.1 p . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.843 0.354 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.3 t -123.89 94.79 45.3 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.102 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.39 98.3 0.39 Allowed 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.522 2.148 . . . . 0.0 112.378 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -130.92 144.7 16.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.435 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 4.0 pttt -116.79 122.38 44.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.758 0.313 . . . . 0.0 110.977 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.532 ' HB ' HG21 ' A' ' 63' ' ' THR . 8.9 p -108.37 134.41 50.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.993 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.5 m -94.39 83.56 4.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.894 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.95 170.09 15.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.699 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -124.26 140.05 53.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.879 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 3.8 mttm -65.83 140.32 58.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.947 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -74.76 -171.01 1.18 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.799 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.85 -27.75 68.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.197 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.16 31.21 2.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.023 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 43.92 33.24 0.72 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.463 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -134.52 112.02 10.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.939 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.516 HG21 HG11 ' A' ' 97' ' ' VAL . 23.1 pt -59.33 -28.73 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.094 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.28 80.27 1.17 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.878 179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.9 pt -156.39 143.35 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.773 0.32 . . . . 0.0 111.099 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.0 m -108.04 138.37 44.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.83 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.8 pp -138.12 174.8 9.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.073 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -172.29 131.29 2.1 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.346 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.03 168.22 41.21 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.431 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -87.34 -135.9 4.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.51 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -159.31 -48.86 0.06 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.798 0.332 . . . . 0.0 111.109 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.3 -53.75 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.815 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -83.22 -30.5 27.66 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 4.4 t -135.39 64.43 59.25 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.976 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.74 -34.11 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.622 2.214 . . . . 0.0 112.22 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.4 ' O ' HD22 ' A' ' 47' ' ' LEU . 2.0 m -60.01 152.26 24.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.01 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.434 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.4 mm? -121.14 143.43 49.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.761 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.47 ' OH ' HD13 ' A' ' 104' ' ' LEU . 0.2 OUTLIER -127.54 149.29 50.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.988 -179.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.797 HD12 ' HB2' ' A' ' 68' ' ' ASP . 29.8 mt -88.7 128.46 40.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.061 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.706 HG21 ' HB3' ' B' ' 122' ' ' SER . 21.1 t -80.09 -56.91 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.276 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -173.04 -178.29 1.76 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.988 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.466 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.6 t -120.95 159.1 23.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.014 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.443 ' CE1' ' HG3' ' B' ' 124' ' ' LYS . 12.1 m-85 -104.06 146.24 29.01 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.678 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -65.09 154.52 37.63 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.01 0.433 . . . . 0.0 111.261 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 28.7 m-80 65.26 22.13 12.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.622 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.43 HG23 ' O ' ' A' ' 53' ' ' PHE . 32.5 p -108.92 148.99 39.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 120.717 0.294 . . . . 0.0 110.562 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -60.14 -27.12 84.23 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.421 2.081 . . . . 0.0 112.07 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.89 48.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -89.97 -27.6 19.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.309 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 52.6 mt -79.74 -37.01 36.47 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.749 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -69.9 -45.06 68.41 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.801 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.8 84.88 1.11 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.639 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.734 HG22 ' OH ' ' A' ' 101' ' ' TYR . 0.2 OUTLIER -161.99 -63.92 0.05 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 179.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.0 136.87 23.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.069 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.54 -175.33 0.78 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.559 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -52.77 134.81 36.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.241 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.17 -33.45 6.57 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.404 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.797 ' HB2' HD12 ' A' ' 49' ' ' ILE . 22.5 m-20 -74.43 130.72 40.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.809 0.338 . . . . 0.0 110.869 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -95.74 108.38 20.69 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.009 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 11.6 tt -73.86 142.39 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.961 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.528 ' HA ' HD11 ' A' ' 78' ' ' ILE . 6.7 t -160.01 42.73 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.013 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 168.87 157.76 11.94 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.624 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.753 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -162.82 122.39 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.179 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 56.36 27.56 12.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.22 -29.56 9.94 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.44 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 1.9 mtm180 -67.03 151.66 47.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.782 0.325 . . . . 0.0 110.934 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 7.5 m -100.22 116.53 32.44 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.528 HD11 ' HA ' ' A' ' 71' ' ' THR . 2.3 pp -91.15 11.81 2.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.53 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -69.0 75.02 0.31 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.857 0.361 . . . . 0.0 110.871 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 136.89 44.01 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.498 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -139.54 154.39 47.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.793 0.33 . . . . 0.0 110.876 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.696 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.8 OUTLIER -77.13 158.28 30.51 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.897 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.02 -30.71 68.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.93 -38.82 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.941 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -68.1 -53.23 26.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.724 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 82' ' ' THR . 3.6 m -59.7 -37.73 72.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.017 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -60.28 -52.23 66.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.975 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.75 -31.8 72.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.708 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.4 ttp -60.28 -52.01 67.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.839 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.753 ' CD1' HG21 ' A' ' 73' ' ' VAL . 28.9 mm -62.42 -39.48 84.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.04 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.514 ' NE2' HG22 ' B' ' 125' ' ' ILE . 58.9 mt-30 -67.92 -27.45 66.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.953 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -78.81 -35.71 43.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.919 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' MET . 21.5 t -59.01 149.73 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.1 mmtm -129.46 168.52 16.21 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.01 -142.31 46.13 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.468 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -78.87 97.18 5.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.87 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG11 HG21 ' A' ' 33' ' ' ILE . 10.3 p -81.46 136.25 23.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.082 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.639 ' C ' HD12 ' A' ' 99' ' ' ILE . 6.0 m -110.98 143.06 42.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.794 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.639 HD12 ' C ' ' A' ' 98' ' ' THR . 3.8 mp -139.06 129.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.127 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -91.2 98.64 11.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.877 179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.734 ' OH ' HG22 ' A' ' 63' ' ' THR . 45.6 p90 -103.88 165.87 10.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.015 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.507 ' O ' HD12 ' A' ' 104' ' ' LEU . 4.8 m-80 -127.76 113.06 15.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.859 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 1.9 tptt -70.8 134.81 47.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.861 -179.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.836 ' HG ' HG22 ' A' ' 18' ' ' THR . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.911 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.794 0.33 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.706 ' HB3' HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -84.87 112.27 20.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.937 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.7 t -83.43 112.76 21.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.183 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.443 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -86.76 126.66 34.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.633 HD13 ' HB ' ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.081 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.465 HG22 ' HB3' ' A' ' 104' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.836 0.351 . . . . 0.0 110.805 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -113.05 90.64 16.34 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.104 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_exo -51.55 107.67 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.505 2.136 . . . . 0.0 112.394 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -128.92 155.02 20.48 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.835 -0.697 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.16 135.38 33.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.812 0.339 . . . . 0.0 110.873 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.557 ' CG2' HG21 ' A' ' 63' ' ' THR . 8.9 p -126.6 139.15 52.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.064 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.2 m -99.38 93.3 5.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.892 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.553 HD12 HD13 ' A' ' 99' ' ' ILE . 2.0 mt -94.57 139.36 31.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.945 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -83.81 132.77 34.79 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' HE2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -62.84 143.71 57.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.882 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -74.72 -170.5 1.07 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.932 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.25 -30.71 71.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.138 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.53 35.31 2.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.715 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 44.21 35.2 1.17 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.264 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 26.9 mt -127.73 98.76 5.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.815 -179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.575 HG23 ' NZ ' ' A' ' 27' ' ' LYS . 10.6 pt -58.73 -25.12 27.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.26 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.24 70.3 1.22 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.578 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.507 ' CD1' HD11 ' A' ' 33' ' ' ILE . 14.6 pt -148.68 144.39 18.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 0.0 110.99 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 29.9 t -110.51 141.95 42.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 2.7 pp -141.37 159.38 22.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.106 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 47' ' ' LEU . . . -128.23 131.26 6.9 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.445 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -151.32 153.82 25.19 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.514 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.411 ' O ' ' CE1' ' A' ' 43' ' ' TYR . . . -168.89 84.22 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.524 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.551 ' H ' HG23 ' A' ' 82' ' ' THR . . . -58.0 -177.68 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.837 0.351 . . . . 0.0 111.188 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 61.54 17.69 8.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.298 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . 0.416 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 14.6 p90 172.0 -35.26 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.619 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 23.4 m -146.53 75.11 12.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.18 -23.5 33.37 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.643 2.229 . . . . 0.0 112.389 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 31.1 m -57.56 133.08 54.95 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.963 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.491 HD13 ' O ' ' A' ' 38' ' ' GLY . 0.3 OUTLIER -99.74 141.99 31.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 -179.989 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -126.5 169.07 13.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.887 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.505 HD11 ' HB ' ' A' ' 70' ' ' ILE . 34.9 mt -129.06 115.04 34.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.165 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.476 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.8 t -89.44 165.72 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.889 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.476 ' H ' HG12 ' A' ' 50' ' ' VAL . 20.8 pt20 -47.07 145.02 2.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.316 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 32.9 m -88.19 -175.76 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.914 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 41.6 m-85 -112.9 147.37 37.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.829 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -63.1 158.91 18.49 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.042 0.449 . . . . 0.0 111.178 -179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 67.47 15.84 9.89 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.795 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 63.4 p -103.05 148.26 35.36 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-O 120.612 0.244 . . . . 0.0 110.582 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.405 ' HG2' ' HA ' ' A' ' 33' ' ' ILE . 17.9 Cg_endo -59.3 -29.75 91.07 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.479 2.119 . . . . 0.0 112.07 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.498 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -76.97 -30.99 56.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.022 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.531 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -89.39 -27.09 20.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.159 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 21.0 mt -76.31 -42.42 45.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.807 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -70.58 -36.03 73.35 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.852 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.49 81.85 0.61 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.557 HG21 ' CG2' ' A' ' 23' ' ' VAL . 2.9 m -155.17 -66.0 0.12 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.811 0.339 . . . . 0.0 110.96 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.498 HG23 ' HB1' ' A' ' 58' ' ' ALA . 18.1 m -91.28 134.77 28.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.162 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.69 -169.69 0.36 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.066 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.442 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -68.46 124.68 24.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.117 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 132.18 -28.38 3.49 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.486 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.7 -179.11 4.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.795 0.331 . . . . 0.0 110.937 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -136.25 118.62 15.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.519 HG23 HD11 ' A' ' 78' ' ' ILE . 14.9 tt -73.05 154.68 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.001 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.4 t -164.0 31.66 0.08 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.04 -179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 166.24 166.21 24.89 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.638 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.852 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.8 p -162.94 119.88 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 111.0 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 60.04 30.47 19.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.9 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.03 -27.8 17.52 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.492 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -75.57 165.28 25.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.902 0.382 . . . . 0.0 110.914 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 2.2 p -105.56 148.16 27.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.848 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.519 HD11 HG23 ' A' ' 70' ' ' ILE . 2.6 pp -125.24 9.01 4.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.567 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.36 -29.14 69.72 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.774 0.321 . . . . 0.0 110.877 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -111.05 39.24 2.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.501 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 5.6 mmmt -131.92 155.29 48.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.857 0.361 . . . . 0.0 111.031 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.551 HG23 ' H ' ' A' ' 41' ' ' ALA . 1.3 m -96.42 172.36 7.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.689 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.481 ' H ' HG22 ' A' ' 82' ' ' THR . 14.2 pttm -55.04 -38.78 68.42 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.051 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.9 m -67.87 -40.42 83.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.011 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -67.8 -48.65 65.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.714 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.483 HG23 ' N ' ' A' ' 87' ' ' ALA . 27.2 m -63.91 -45.0 98.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.014 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.483 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.63 -38.75 78.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.058 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 31.3 mttt -74.64 -32.95 62.44 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.885 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.445 ' O ' HG12 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -63.24 -40.83 98.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.852 ' CD1' HG21 ' A' ' 73' ' ' VAL . 36.1 mm -77.9 -46.06 27.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.12 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.94 -25.62 66.93 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.097 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -86.2 -54.41 4.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.065 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 90' ' ' ILE . 11.1 p -55.69 153.56 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.172 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -133.3 -177.21 4.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.784 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 64.98 -168.64 28.58 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.3 pm0 -63.84 108.82 1.56 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.84 0.352 . . . . 0.0 110.996 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.692 HG11 ' HE2' ' A' ' 27' ' ' LYS . 14.3 m -95.23 143.77 11.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.039 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 m -117.33 103.87 10.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.022 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.559 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.1 mp -93.65 126.96 46.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.947 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.409 ' N ' ' CD2' ' A' ' 100' ' ' HIS . 5.1 m-70 -90.73 109.78 20.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -116.47 166.64 11.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.839 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.4 m-80 -126.83 136.82 52.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.841 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.9 mttp -94.23 128.06 40.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.791 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.465 ' HB3' HG22 ' A' ' 18' ' ' THR . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.981 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 61.9 tt0 . . . . . 0 C--O 1.232 0.138 0 CA-C-O 120.806 0.336 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 31.4 m -135.21 150.86 50.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.829 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -106.86 130.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.138 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 118.04 36.15 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.961 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.612 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.123 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.558 HG22 HD21 ' A' ' 104' ' ' LEU . 13.2 p . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.857 0.36 . . . . 0.0 110.894 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.27 98.7 51.14 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.75 119.2 6.21 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.399 2.066 . . . . 0.0 112.38 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -146.08 124.14 1.99 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.452 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 13.9 pttp -103.35 119.78 39.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.77 0.319 . . . . 0.0 111.099 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 63' ' ' THR . 12.2 p -112.26 139.75 35.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.017 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.478 HG22 ' HB2' ' A' ' 96' ' ' GLU . 7.1 m -101.88 94.06 5.61 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.005 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.668 HD22 HG22 ' A' ' 23' ' ' VAL . 3.9 mm? -90.94 161.62 15.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.746 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.7 mp0 -106.06 130.75 53.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.539 ' NZ ' HG22 ' A' ' 90' ' ' ILE . 0.4 OUTLIER -65.11 130.98 45.33 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.904 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -65.27 -170.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.992 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -67.21 -28.54 68.16 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.217 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.462 ' HB2' HD12 ' A' ' 32' ' ' LEU . 3.8 mm-40 -98.11 32.42 2.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.95 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 44.0 31.08 0.47 Allowed 'General case' 0 N--CA 1.462 0.15 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.361 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 30' ' ' GLN . 3.6 mt -130.09 106.99 8.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.833 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.512 HD11 ' CD1' ' A' ' 35' ' ' ILE . 21.0 pt -58.23 -25.59 27.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.277 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.93 73.13 1.28 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.623 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.69 HD11 HD11 ' B' ' 125' ' ' ILE . 14.7 pt -152.25 145.44 15.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.782 0.325 . . . . 0.0 111.103 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.9 m -109.11 150.88 27.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.816 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 1.9 pt -149.53 149.11 15.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.102 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -136.6 110.06 0.77 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.823 -0.704 . . . . 0.0 112.561 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.48 ' HA3' HD22 ' A' ' 47' ' ' LEU . . . -158.92 167.47 34.8 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.482 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.57 ' C ' HG23 ' A' ' 82' ' ' THR . . . -129.28 -126.65 2.86 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.503 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -166.7 158.2 12.87 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.732 0.301 . . . . 0.0 111.174 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 67.4 -69.96 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.055 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -88.36 -39.93 13.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.878 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 56.4 m -125.81 69.33 64.25 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.922 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.97 -30.12 14.2 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.629 2.219 . . . . 0.0 112.312 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -60.49 145.04 49.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.48 HD22 ' HA3' ' A' ' 39' ' ' GLY . 2.8 mm? -117.9 118.55 32.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.808 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -97.97 125.48 42.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.906 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.595 HD12 ' HB2' ' A' ' 68' ' ' ASP . 38.5 mt -81.46 130.71 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.239 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.1 t -102.44 167.27 2.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.825 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.516 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 20.1 pt20 -47.8 148.6 1.53 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.799 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 33.4 m -94.05 -175.81 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 59.3 m-85 -112.19 149.01 32.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.779 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -64.36 158.61 23.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 20.4 m-80 67.44 17.45 10.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.579 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 46.8 p -105.15 150.3 38.65 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 120.732 0.301 . . . . 0.0 110.558 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -62.12 -29.45 81.0 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.545 2.163 . . . . 0.0 112.165 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HB1' ' CG2' ' A' ' 64' ' ' VAL . . . -78.01 -36.03 49.19 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.172 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.799 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -84.37 -29.29 26.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.167 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 33.6 mt -76.62 -40.2 50.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.852 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -72.12 -31.82 66.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.958 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.63 73.58 0.85 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.551 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -146.86 -60.07 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.831 0.348 . . . . 0.0 110.895 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.661 HG13 HG11 ' A' ' 23' ' ' VAL . 28.8 m -101.36 132.57 46.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.153 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.96 -169.06 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -59.28 131.32 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.013 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 107.83 26.6 5.49 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.474 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.595 ' HB2' HD12 ' A' ' 49' ' ' ILE . 74.7 m-20 -140.76 171.57 13.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.833 0.349 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -130.12 103.83 6.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.854 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 tt -69.92 142.67 15.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.03 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.586 ' HA ' HD11 ' A' ' 78' ' ' ILE . 8.9 t -164.74 39.21 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.015 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 172.63 152.03 8.35 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.644 -0.788 . . . . 0.0 112.656 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.712 HG11 HD13 ' A' ' 90' ' ' ILE . 16.8 t -151.64 127.17 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.762 0.315 . . . . 0.0 110.998 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 20.0 p30 44.76 30.75 0.57 Allowed 'General case' 0 C--O 1.231 0.13 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.404 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.2 -33.23 6.32 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.534 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.65 157.19 30.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.773 0.321 . . . . 0.0 110.981 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -100.79 144.17 30.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.876 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.662 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -127.58 16.78 3.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.397 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -33.55 71.51 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.799 0.333 . . . . 0.0 111.028 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -105.87 46.1 1.22 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 mmtt -137.05 150.92 48.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.823 0.344 . . . . 0.0 110.943 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.57 HG23 ' C ' ' A' ' 40' ' ' GLY . 0.8 OUTLIER -89.62 173.25 8.41 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.925 179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.475 ' H ' HG22 ' A' ' 82' ' ' THR . 12.0 pttm -57.37 -36.91 71.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.964 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.8 m -72.16 -35.7 53.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.07 179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -70.07 -49.39 51.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.757 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 82' ' ' THR . 22.2 t -64.33 -36.83 78.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.873 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.498 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -61.06 -52.45 64.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.961 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.09 -32.03 72.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.65 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.579 ' O ' HG23 ' A' ' 93' ' ' VAL . 3.9 ttm -59.23 -58.38 8.88 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.789 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.785 HG21 HD13 ' B' ' 125' ' ' ILE . 33.9 mm -56.53 -47.97 81.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.104 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.696 HE21 HG22 ' B' ' 125' ' ' ILE . 43.5 mt-30 -58.7 -28.32 65.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.893 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -77.32 -34.4 55.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.926 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.857 HG11 HG12 ' A' ' 97' ' ' VAL . 13.1 t -63.4 159.66 3.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.136 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -140.2 142.94 35.83 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 86.52 -138.67 15.95 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.564 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.478 ' HB2' HG22 ' A' ' 24' ' ' THR . 1.2 pm0 -84.08 117.77 23.65 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.75 0.31 . . . . 0.0 110.877 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.857 HG12 HG11 ' A' ' 93' ' ' VAL . 11.4 m -101.2 135.86 35.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.13 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.8 m -106.48 95.06 5.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 99' ' ' ILE . 3.7 mp -93.23 129.24 43.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.11 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -96.21 107.6 19.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.879 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.651 ' CD2' HG12 ' A' ' 64' ' ' VAL . 24.5 p90 -115.65 148.33 39.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.949 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 9.2 m-20 -109.4 119.93 40.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.909 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -70.04 146.43 50.99 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.906 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.558 HD21 HG22 ' A' ' 18' ' ' THR . 27.1 mt . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.935 0.398 . . . . 0.0 110.817 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.25 117.18 26.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.853 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.498 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.9 t -70.64 112.94 5.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.085 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.16 129.53 34.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.945 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.785 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.6 p . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.821 0.343 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 20.6 t -116.2 91.24 31.71 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.14 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.05 107.82 1.6 Allowed 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.514 2.143 . . . . 0.0 112.257 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -132.98 138.09 9.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.545 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.77 133.35 54.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.83 0.348 . . . . 0.0 110.886 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.713 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -122.53 140.98 44.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.029 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.1 m -98.25 93.86 6.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.976 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.814 HD12 HD13 ' A' ' 99' ' ' ILE . 2.1 mt -100.72 135.55 41.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -94.94 144.24 25.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.867 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -60.23 158.3 11.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.924 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -89.08 -169.81 2.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.43 -30.31 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.093 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.92 25.47 7.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.829 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 5.6 t30 54.04 28.71 9.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 110.786 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 19.6 mt -126.4 105.09 8.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.978 -179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.1 pt -54.83 -27.77 19.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.158 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 85.06 76.66 1.2 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.909 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.578 HD11 HD11 ' B' ' 125' ' ' ILE . 2.6 pt -158.43 132.27 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.782 0.325 . . . . 0.0 111.065 179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.9 t -97.94 152.86 18.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.858 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 4.0 pt -144.08 167.26 12.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.171 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -158.93 116.79 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.492 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.06 164.35 37.72 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.446 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.94 -119.73 3.06 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.444 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.665 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -175.44 -65.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 111.175 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.1 mt-30 -81.81 -69.49 0.61 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.901 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 18.9 m-85 -71.94 -47.14 54.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.7 m -115.98 74.45 5.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -69.06 -21.84 36.17 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.48 2.12 . . . . 0.0 112.435 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -57.64 121.8 11.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.004 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.04 127.21 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.746 179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -116.68 169.42 9.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.092 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 42.5 mt -117.9 137.02 53.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.001 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG12 ' H ' ' A' ' 51' ' ' GLN . 2.7 t -105.8 166.8 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.839 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.671 ' N ' ' HB2' ' A' ' 66' ' ' ALA . 4.7 pt20 -45.15 147.64 0.7 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.868 0.366 . . . . 0.0 111.538 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' HB2' ' A' ' 59' ' ' ALA . 25.0 m -97.14 -175.49 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.985 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.457 ' O ' HG23 ' A' ' 56' ' ' THR . 27.2 m-85 -112.14 147.35 36.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.565 179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.42 160.03 20.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.019 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 66.83 15.92 10.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.639 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 53' ' ' PHE . 44.2 p -104.22 151.32 39.03 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.595 0.236 . . . . 0.0 110.505 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -60.69 -31.82 92.44 Favored 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.449 2.099 . . . . 0.0 112.067 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.576 ' HB1' HG23 ' A' ' 64' ' ' VAL . . . -74.06 -37.53 64.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.23 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.498 ' HB2' ' CG2' ' A' ' 52' ' ' VAL . . . -77.6 -47.76 18.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.063 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 50.9 mt -58.73 -48.97 79.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.918 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -63.12 -33.73 76.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.37 71.6 0.99 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.488 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.713 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -141.46 -62.62 0.46 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.839 0.352 . . . . 0.0 110.89 -179.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.576 HG23 ' HB1' ' A' ' 58' ' ' ALA . 15.7 m -97.22 133.45 38.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.067 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -170.91 -170.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.091 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.671 ' HB2' ' N ' ' A' ' 51' ' ' GLN . . . -65.42 115.09 5.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.924 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.84 -40.81 1.49 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.53 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -79.74 158.16 26.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.709 0.29 . . . . 0.0 110.981 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.0 tt0 -114.79 115.47 27.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.2 tt -70.07 149.22 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.044 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.7 t -167.44 38.65 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.934 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 169.64 149.11 6.14 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.599 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.774 HG21 HD13 ' A' ' 90' ' ' ILE . 10.9 p -154.58 115.92 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.749 0.309 . . . . 0.0 111.004 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 60.68 27.42 17.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.024 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.65 14.9 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.585 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.17 161.18 30.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.76 0.314 . . . . 0.0 110.885 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 26.2 t -97.96 141.08 31.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.429 HG22 ' CE ' ' A' ' 89' ' ' MET . 1.1 pt -112.64 -15.81 9.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.568 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -61.34 82.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.885 0.374 . . . . 0.0 110.877 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 153.86 -26.38 0.73 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.605 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -81.65 169.62 16.79 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.911 0.386 . . . . 0.0 110.852 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.821 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.4 OUTLIER -89.44 175.37 7.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.479 ' H ' HG22 ' A' ' 82' ' ' THR . 1.2 ttpm? -59.25 -49.24 78.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.867 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.407 HG23 ' N ' ' A' ' 85' ' ' GLU . 30.2 m -63.6 -40.77 90.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.007 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.407 ' N ' HG23 ' A' ' 84' ' ' VAL . 8.2 mm-40 -61.27 -46.23 91.21 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.844 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.821 HG23 ' O ' ' A' ' 82' ' ' THR . 31.5 t -65.03 -55.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.11 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -49.02 -55.19 12.76 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.326 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.14 72.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.709 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.429 ' CE ' HG22 ' A' ' 78' ' ' ILE . 1.6 ttp -60.32 -38.27 83.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.842 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.939 HG21 HD13 ' B' ' 125' ' ' ILE . 31.8 mm -68.81 -48.2 72.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.019 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -64.76 -20.65 66.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.246 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -81.93 -42.65 19.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.528 -179.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.572 HG13 HG22 ' A' ' 97' ' ' VAL . 7.2 p -66.31 74.86 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.038 0.447 . . . . 0.0 111.358 -179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.12 142.02 52.6 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.931 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 100.99 -155.19 19.22 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.519 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -69.14 104.94 2.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.889 0.376 . . . . 0.0 110.887 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.572 HG22 HG13 ' A' ' 93' ' ' VAL . 22.0 t -84.35 123.63 39.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.176 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.6 m -106.59 106.44 16.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.965 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.814 HD13 HD12 ' A' ' 25' ' ' LEU . 3.3 mp -100.46 133.84 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.21 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -97.89 98.52 9.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.875 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -101.25 162.16 13.1 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.019 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 32.5 m-20 -129.83 112.84 13.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.953 179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -69.99 127.56 33.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.885 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.878 0.371 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 7.3 m -123.58 116.83 23.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . . . . . . . . . 24.5 t -74.88 129.93 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.082 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.71 119.15 38.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.832 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.939 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.25 1.088 0 CA-C-O 118.288 -0.863 . . . . 0.0 111.14 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.668 HG23 ' CD1' ' A' ' 104' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.773 0.321 . . . . 0.0 110.819 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.459 ' O ' HG13 ' A' ' 19' ' ' VAL . 12.8 p -106.49 123.57 38.36 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.939 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.47 146.94 86.37 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.471 2.114 . . . . 0.0 112.316 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -156.16 116.62 0.73 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.336 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.54 125.68 51.31 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.844 0.354 . . . . 0.0 111.03 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG13 HD11 ' A' ' 25' ' ' LEU . 9.3 p -129.2 131.6 67.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.02 179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 96' ' ' GLU . 2.9 m -93.01 99.06 11.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.985 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.465 HD11 HG13 ' A' ' 23' ' ' VAL . 0.4 OUTLIER -109.29 136.94 47.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.873 179.746 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -85.64 167.01 15.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.892 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.724 ' HE2' HG21 ' A' ' 97' ' ' VAL . 2.6 mmtm -80.32 154.16 27.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -86.02 -175.4 5.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.818 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -59.63 -28.46 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.54 22.51 10.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.067 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 40.5 t30 54.54 35.53 23.67 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.138 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.443 HD21 ' HG2' ' A' ' 91' ' ' GLN . 18.8 mt -143.36 115.26 8.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.91 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 ' CD1' ' A' ' 35' ' ' ILE . 22.4 pt -60.31 -29.63 44.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.184 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.95 79.52 1.31 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.612 179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.479 HD11 HD11 ' B' ' 125' ' ' ILE . 15.8 pt -156.78 152.56 7.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.86 0.362 . . . . 0.0 111.011 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 26.7 t -118.41 140.53 49.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.956 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.521 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -133.04 159.66 43.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.155 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.73 117.4 0.8 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.49 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -169.65 143.08 7.69 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.498 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.6 -128.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.524 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -173.31 -41.41 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.768 0.318 . . . . 0.0 111.091 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -100.47 -32.61 10.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.86 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -110.0 -31.73 7.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.897 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.6 m -134.49 64.37 63.88 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.88 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.11 -29.53 66.22 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.587 2.191 . . . . 0.0 112.243 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -66.82 124.46 22.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD2' HG21 ' A' ' 86' ' ' VAL . 7.2 mp -102.55 138.5 39.37 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.912 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.414 ' CE1' ' HG3' ' A' ' 69' ' ' GLU . 12.6 m-85 -128.99 153.66 47.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.021 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.885 HD12 ' HB2' ' A' ' 68' ' ' ASP . 24.2 mt -89.25 140.52 15.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.053 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.504 HG21 ' CB ' ' B' ' 122' ' ' SER . 19.9 t -87.23 -63.4 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.21 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.45 ' HG2' HG12 ' A' ' 50' ' ' VAL . 4.1 pt20 -168.8 174.96 6.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.01 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 1.9 t -114.12 159.73 13.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG23 ' A' ' 56' ' ' THR . 9.7 m-85 -103.87 144.04 32.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.519 179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -64.63 154.92 34.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.977 0.418 . . . . 0.0 111.241 -179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 65.25 22.18 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.614 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.441 HG23 ' O ' ' A' ' 53' ' ' PHE . 25.1 p -111.66 154.26 44.01 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 120.587 0.232 . . . . 0.0 110.764 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 27.0 Cg_endo -62.48 -27.58 77.11 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.46 2.106 . . . . 0.0 112.126 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.92 -35.97 49.94 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.083 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.515 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -87.38 -26.2 23.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 18.3 mt -78.79 -39.65 35.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.891 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -66.89 -53.6 30.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.785 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 94.45 67.15 1.02 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.404 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -144.38 -64.45 0.36 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.731 0.3 . . . . 0.0 110.898 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.1 m -95.04 127.53 46.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.085 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -164.04 -167.84 1.44 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.229 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -55.75 139.23 45.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.235 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 97.79 -28.47 14.26 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.443 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.885 ' HB2' HD12 ' A' ' 49' ' ' ILE . 0.9 OUTLIER -75.38 147.94 39.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.916 0.389 . . . . 0.0 110.814 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.414 ' HG3' ' CE1' ' A' ' 48' ' ' TYR . 4.3 tt0 -111.69 111.81 23.06 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.904 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.5 tt -76.45 131.64 34.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.963 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.585 ' HA ' HD11 ' A' ' 78' ' ' ILE . 5.6 t -153.51 34.77 0.45 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.888 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 177.97 141.01 4.01 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.732 -0.746 . . . . 0.0 112.544 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.79 HG11 HD13 ' A' ' 90' ' ' ILE . 21.8 t -150.16 112.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.882 0.372 . . . . 0.0 111.01 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.587 ' OD1' HG21 ' A' ' 93' ' ' VAL . 28.3 m120 60.76 26.96 16.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.929 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.5 -27.5 15.41 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.516 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.4 mtt180 -68.47 141.2 55.68 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.881 0.372 . . . . 0.0 110.977 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.8 t -87.17 110.82 20.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.848 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.604 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.5 pp -92.06 14.58 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.518 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -67.87 -29.86 69.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.804 0.335 . . . . 0.0 110.852 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.21 32.6 7.39 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.571 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 mtmt -131.56 154.44 48.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.842 0.353 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.499 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -86.32 173.98 9.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.888 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 25.6 pttt -58.94 -37.88 77.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.902 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.5 m -72.45 -34.99 50.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.055 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -66.53 -50.81 61.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.827 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.629 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.2 t -61.94 -48.06 90.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.086 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.51 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -51.4 -53.61 34.94 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.299 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -35.52 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.478 ' HE2' HG22 ' A' ' 78' ' ' ILE . 1.3 ttp -60.65 -43.98 96.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.899 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 1.008 HG21 HD13 ' B' ' 125' ' ' ILE . 40.6 mm -63.0 -55.33 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.997 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.443 ' HG2' HD21 ' A' ' 32' ' ' LEU . 56.1 mt-30 -56.1 -26.67 50.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.154 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.87 -54.93 5.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.019 -179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.587 HG21 ' OD1' ' A' ' 74' ' ' ASN . 12.7 p -57.71 151.16 3.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.28 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -127.15 -177.24 3.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.911 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 60.57 -164.65 15.5 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.431 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HB2' HG22 ' A' ' 24' ' ' THR . 10.5 pt-20 -59.7 109.78 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.885 0.374 . . . . 0.0 110.823 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.724 HG21 ' HE2' ' A' ' 27' ' ' LYS . 19.3 t -96.25 123.75 48.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.125 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.425 ' OG1' HG23 ' A' ' 24' ' ' THR . 3.0 m -102.9 121.39 42.41 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.058 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.405 HD12 ' N ' ' A' ' 99' ' ' ILE . 5.2 mp -113.11 133.76 57.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.931 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -93.38 92.44 7.66 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.781 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -95.31 158.56 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.994 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -130.46 112.88 13.64 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.835 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 20.3 mttt -69.94 136.64 50.77 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.005 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.668 ' CD1' HG23 ' A' ' 18' ' ' THR . 4.5 mm? . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.918 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.799 0.333 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . 0.504 ' CB ' HG21 ' A' ' 50' ' ' VAL . 71.1 m -108.05 128.41 54.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.866 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.51 HG11 ' CB ' ' A' ' 87' ' ' ALA . 26.8 t -76.47 141.97 14.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -117.23 136.42 53.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.891 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 1.008 HD13 HG21 ' A' ' 90' ' ' ILE . 2.8 pp . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.281 -0.866 . . . . 0.0 111.089 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.418 HG22 HD23 ' A' ' 104' ' ' LEU . 43.3 p . . . . . 0 N--CA 1.458 -0.067 0 CA-C-O 120.776 0.322 . . . . 0.0 110.855 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.72 79.1 30.83 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.153 -179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.53 111.74 0.97 Allowed 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.602 2.201 . . . . 0.0 112.106 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.03 144.34 13.7 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.509 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.2 114.6 16.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.847 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 p -102.52 150.25 6.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.153 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.581 HG22 ' HB2' ' A' ' 96' ' ' GLU . 6.4 m -108.74 87.39 2.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.898 179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 mt -94.43 141.41 28.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.858 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 33' ' ' ILE . 12.7 mp0 -89.48 170.11 10.8 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.837 ' HE2' HG21 ' A' ' 97' ' ' VAL . 68.1 mmtt -89.84 163.91 14.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.942 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.1 p30 -99.52 -170.74 1.95 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.857 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.99 63.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.248 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.498 ' HB2' HD12 ' A' ' 32' ' ' LEU . 1.5 mm-40 -95.1 19.15 10.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.185 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 1.4 t30 53.24 41.92 32.12 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.947 0.403 . . . . 0.0 110.769 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.498 HD12 ' HB2' ' A' ' 30' ' ' GLN . 4.9 mt -140.2 115.2 9.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.116 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.769 HG23 ' HD3' ' A' ' 27' ' ' LYS . 16.6 pt -59.62 -29.4 42.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.085 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.748 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 89.57 83.18 1.33 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.9 179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.748 HG23 ' O ' ' A' ' 34' ' ' GLY . 0.7 OUTLIER -167.46 135.87 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.685 0.279 . . . . 0.0 110.84 179.635 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.9 m -101.94 139.27 37.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.883 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.4 pt -123.83 164.44 21.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.018 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.05 123.24 2.07 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.521 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.466 ' HA3' HD13 ' A' ' 47' ' ' LEU . . . -170.11 156.52 27.23 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.521 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -113.88 -128.28 4.68 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.456 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -164.25 147.45 9.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.666 0.27 . . . . 0.0 111.089 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 65.07 -75.39 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.042 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -77.8 -34.33 52.16 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.864 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 2.3 m -131.2 60.9 56.14 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.993 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -74.87 -7.07 18.91 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.532 2.154 . . . . 0.0 112.701 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 85.5 m -76.88 127.7 33.2 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.944 0.402 . . . . 0.0 111.019 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' HG21 ' A' ' 86' ' ' VAL . 3.5 mm? -108.84 141.72 40.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.804 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.587 ' HA ' HG22 ' A' ' 70' ' ' ILE . 39.8 p90 -148.23 173.8 12.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.083 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 2.1 mt -93.22 152.77 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.097 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 51' ' ' GLN . 30.2 m -117.41 -45.83 3.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.327 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.472 ' N ' HG23 ' A' ' 50' ' ' VAL . 5.3 pt20 -172.43 -178.95 2.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.988 0.423 . . . . 0.0 111.013 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 53' ' ' PHE . 4.0 t -127.79 165.25 27.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.129 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.505 ' N ' HG12 ' A' ' 52' ' ' VAL . 5.7 m-85 -104.54 157.3 17.26 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.469 179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -78.12 153.55 32.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.959 0.409 . . . . 0.0 111.22 -179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 63.2 25.55 14.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.823 179.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.425 HG21 ' HB2' ' A' ' 53' ' ' PHE . 41.3 p -106.29 148.02 35.94 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-O 120.592 0.234 . . . . 0.0 110.615 179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.67 -30.53 84.21 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.529 2.153 . . . . 0.0 112.117 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -74.22 -35.24 63.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.945 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -84.69 -28.49 26.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.12 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 10.8 mt -74.92 -35.57 62.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.729 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.65 -49.89 15.08 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.768 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.76 87.09 1.47 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.492 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -160.7 -64.96 0.06 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.838 0.351 . . . . 0.0 110.914 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.1 m -92.63 134.48 30.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -176.11 -174.4 0.63 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.117 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -57.37 148.19 23.84 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.117 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 101.23 -29.37 12.67 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.368 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.05 166.36 13.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -127.42 108.93 11.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.911 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.587 HG22 ' HA ' ' A' ' 48' ' ' TYR . 18.6 tt -70.14 144.51 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.994 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 4.0 t -153.84 27.66 0.48 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.048 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 174.34 165.49 30.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.534 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.85 HG21 ' CD1' ' A' ' 90' ' ' ILE . 11.9 p -160.5 118.21 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.798 0.333 . . . . 0.0 111.051 179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.3 m120 59.47 29.55 19.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.869 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.21 -28.0 14.69 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.518 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.71 162.9 28.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.817 0.341 . . . . 0.0 110.941 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 42.4 t -101.04 138.02 38.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.869 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.1 pp -112.46 -18.97 7.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.433 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -61.58 83.4 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.862 0.363 . . . . 0.0 110.92 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 154.39 -26.98 0.69 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.523 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.2 mttm -82.95 179.4 7.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.788 0.327 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.527 ' O ' HG23 ' A' ' 86' ' ' VAL . 11.2 m -97.82 164.58 12.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.853 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.421 ' HA ' HD11 ' A' ' 47' ' ' LEU . 1.1 pttm -57.01 -34.82 68.54 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.952 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.6 p -73.46 -40.14 55.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.983 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' N ' HG13 ' A' ' 84' ' ' VAL . 1.7 mm-40 -63.87 -51.78 62.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.789 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.548 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.8 t -58.96 -47.65 89.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.992 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.417 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -54.82 -40.5 69.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.185 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -69.2 -31.71 70.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.768 179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.699 ' O ' HG23 ' A' ' 93' ' ' VAL . 2.7 ttp -66.04 -45.04 82.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.85 ' CD1' HG21 ' A' ' 73' ' ' VAL . 15.6 mm -65.17 -46.42 91.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 50.7 mt-30 -64.52 -30.4 71.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.828 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -42.16 76.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.771 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.699 HG23 ' O ' ' A' ' 89' ' ' MET . 28.6 t -59.8 148.02 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.127 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.14 141.03 51.6 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.843 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 89.92 -136.93 13.77 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.452 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.581 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.5 OUTLIER -78.74 105.37 10.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.815 0.34 . . . . 0.0 110.906 -179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG21 ' HE2' ' A' ' 27' ' ' LYS . 21.6 t -91.02 138.77 18.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.062 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.442 ' O ' HD13 ' A' ' 99' ' ' ILE . 0.2 OUTLIER -106.41 139.13 41.37 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.949 -179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.561 HD13 HG23 ' A' ' 73' ' ' VAL . 25.3 mm -129.66 129.1 66.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.036 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -93.4 97.11 10.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.869 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 13.8 p90 -104.46 149.44 25.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -131.24 115.6 16.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 4.1 mttt -72.42 135.03 45.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.925 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.418 HD23 HG22 ' A' ' 18' ' ' THR . 6.2 mt . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.935 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.785 0.326 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -111.38 118.12 34.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.417 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.5 t -80.85 135.57 24.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.144 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.432 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -107.11 125.7 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.023 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.672 HD13 HG21 ' A' ' 90' ' ' ILE . 2.4 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.266 -0.873 . . . . 0.0 111.139 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 16.3 p . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.869 0.366 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 t -136.57 90.52 17.01 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.111 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.58 104.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.452 2.101 . . . . 0.0 112.471 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -137.46 132.96 6.16 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.414 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.446 ' HD2' ' CE1' ' A' ' 100' ' ' HIS . 3.5 pttt -116.74 138.89 51.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.774 0.321 . . . . 0.0 110.947 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.601 ' CG2' HG21 ' A' ' 63' ' ' THR . 11.3 p -121.87 142.85 36.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.061 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.6 m -95.58 81.38 3.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.923 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.806 HD12 HD13 ' A' ' 99' ' ' ILE . 5.9 mt -75.71 170.02 16.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.785 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.443 ' O ' HG22 ' A' ' 33' ' ' ILE . 8.7 mp0 -124.79 149.68 47.12 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.862 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 11.2 mmtt -69.43 137.94 53.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.891 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -79.32 -176.21 5.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -57.92 -25.85 61.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.221 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.456 ' HB2' HD12 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -102.76 24.25 10.88 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.713 179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 30.8 t30 53.82 30.02 10.68 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.913 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.456 HD12 ' HB2' ' A' ' 30' ' ' GLN . 11.5 mt -134.28 110.05 9.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.045 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.55 HG21 ' CG1' ' A' ' 97' ' ' VAL . 16.9 pt -56.67 -28.15 27.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.171 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.608 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.45 84.33 0.96 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.802 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.608 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.9 pt -161.42 122.22 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.779 0.323 . . . . 0.0 110.929 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.5 t -89.53 134.35 34.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.716 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 11.2 pt -116.49 178.43 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.142 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.06 117.0 0.75 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.468 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.05 169.97 42.55 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.519 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -143.18 -116.83 1.18 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.406 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -170.22 132.63 1.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.781 0.324 . . . . 0.0 111.139 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 1.8 tp60 68.6 -68.97 0.16 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.94 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -69.09 -33.98 74.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.847 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -153.11 69.09 6.8 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -72.23 -24.55 19.77 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 28.9 m -61.36 114.82 3.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.131 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.561 HD21 ' HA ' ' A' ' 83' ' ' LYS . 7.8 mp -102.55 129.09 49.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.644 179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.496 ' HA ' HG22 ' A' ' 70' ' ' ILE . 22.0 p90 -147.57 161.33 41.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.172 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.405 HG22 ' N ' ' A' ' 50' ' ' VAL . 37.3 mt -73.81 155.33 6.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.835 179.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 51' ' ' GLN . 32.3 m -120.42 -47.25 2.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 111.931 0.345 . . . . 0.0 111.931 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.506 ' N ' HG23 ' A' ' 50' ' ' VAL . 1.6 tp60 -168.25 146.84 4.41 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.969 0.414 . . . . 0.0 111.294 -179.402 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.483 ' CG1' ' HB2' ' A' ' 59' ' ' ALA . 3.4 t -102.42 165.07 3.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.791 179.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.477 ' N ' HG12 ' A' ' 52' ' ' VAL . 77.4 m-85 -112.11 154.32 25.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.732 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -69.84 160.33 31.98 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.2 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 63.42 17.15 10.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.88 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 37.9 p -106.71 149.78 38.85 Favored Pre-proline 0 C--N 1.332 -0.182 0 CA-C-O 120.654 0.264 . . . . 0.0 110.545 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.98 -30.57 91.98 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.627 2.218 . . . . 0.0 112.26 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.8 -38.81 67.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.279 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB2' ' CG1' ' A' ' 52' ' ' VAL . . . -85.98 -27.13 25.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.367 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 44.8 mt -75.96 -32.65 59.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.726 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -81.04 -45.39 16.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.867 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.79 64.91 1.41 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.421 179.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.601 HG21 ' CG2' ' A' ' 23' ' ' VAL . 1.2 m -134.9 -56.77 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.798 0.332 . . . . 0.0 111.025 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG12 ' CD2' ' A' ' 101' ' ' TYR . 30.2 m -107.04 134.6 48.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.172 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -175.27 -168.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.143 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.63 120.44 7.78 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.116 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.66 -26.21 6.32 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.427 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -90.0 158.66 17.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.912 0.386 . . . . 0.0 110.768 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 66.2 tt0 -119.55 106.63 12.39 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.973 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.496 HG22 ' HA ' ' A' ' 48' ' ' TYR . 11.4 tt -69.99 139.39 20.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.918 179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 t -161.34 39.9 0.14 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.033 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.75 151.58 7.85 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.632 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.705 HG11 HD13 ' A' ' 90' ' ' ILE . 35.3 t -153.77 124.38 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.915 0.388 . . . . 0.0 111.102 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 57.72 29.3 17.14 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.059 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 96.55 -29.64 10.03 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.569 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 3.7 mtt180 -75.71 166.09 24.07 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.759 0.314 . . . . 0.0 110.968 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 10.8 p -101.37 145.68 28.6 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.892 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.467 ' HB ' HG22 ' A' ' 86' ' ' VAL . 2.6 pp -121.71 -2.93 8.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.664 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -59.16 -30.01 67.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.734 0.302 . . . . 0.0 110.897 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.01 -26.01 25.3 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.638 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -73.75 160.36 31.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.854 0.359 . . . . 0.0 110.954 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 1.2 m -87.79 163.56 16.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.882 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.561 ' HA ' HD21 ' A' ' 47' ' ' LEU . 5.3 ttpm? -53.18 -38.83 63.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.1 p -69.24 -35.83 69.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.003 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 64.0 mm-40 -68.61 -50.3 52.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.021 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.493 HG21 ' CD2' ' A' ' 47' ' ' LEU . 25.0 t -60.27 -49.23 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -53.29 -57.09 11.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.25 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 2.4 tttm -60.54 -31.55 70.65 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.726 ' O ' HG23 ' A' ' 93' ' ' VAL . 1.1 ttt -62.25 -55.61 26.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.94 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.705 HD13 HG11 ' A' ' 73' ' ' VAL . 34.2 mm -56.43 -45.57 81.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.078 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -62.88 -27.67 69.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.874 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -79.69 -35.73 38.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.962 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 89' ' ' MET . 22.4 t -59.16 147.36 8.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.253 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.2 mmtt -128.89 145.79 51.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 82.76 -157.7 36.15 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.584 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -60.21 95.61 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.887 0.375 . . . . 0.0 110.921 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.55 ' CG1' HG21 ' A' ' 33' ' ' ILE . 8.2 p -83.18 126.68 40.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.081 179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.693 ' C ' HD12 ' A' ' 99' ' ' ILE . 31.7 m -100.67 145.53 28.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.806 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -139.67 131.31 33.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.146 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . 0.446 ' CE1' ' HD2' ' A' ' 22' ' ' LYS . 27.7 m-70 -95.1 103.54 15.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.84 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.478 ' CD2' HG12 ' A' ' 64' ' ' VAL . 35.5 p90 -109.37 166.21 11.05 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.861 -179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.8 m-80 -127.5 117.87 22.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.987 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.28 134.99 38.4 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.862 179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.884 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.786 0.327 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 2.8 m -85.75 141.95 29.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.908 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.545 HG23 ' HD2' ' A' ' 83' ' ' LYS . 27.8 t -109.46 119.5 58.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.433 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 5.8 tmtt? -82.54 126.02 31.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 90' ' ' ILE . 2.0 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.486 HG22 ' HG ' ' A' ' 104' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.823 0.344 . . . . 0.0 110.952 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.32 91.71 17.12 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.056 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -51.68 118.39 4.39 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.538 2.158 . . . . 0.0 112.379 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -143.78 131.07 4.29 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.503 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.87 118.52 33.22 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.87 0.367 . . . . 0.0 110.805 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.731 ' CB ' HG21 ' A' ' 63' ' ' THR . 8.6 p -110.98 146.6 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.084 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.1 m -112.36 91.43 3.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.943 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.5 mt -99.15 142.75 30.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.919 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -96.32 144.52 26.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.864 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.666 ' HE2' HG21 ' A' ' 97' ' ' VAL . 5.0 mmtm -59.97 157.19 13.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.902 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 58.4 p30 -96.78 -171.29 2.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.812 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.69 -29.88 62.85 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.234 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -94.09 16.65 14.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.308 179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 4.1 t30 53.07 27.92 6.27 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.891 0.377 . . . . 0.0 110.925 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.5 mt -135.43 112.19 10.12 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.524 HD11 HD11 ' A' ' 35' ' ' ILE . 9.7 pt -59.01 -28.4 38.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.012 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.532 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 90.01 77.83 1.33 Allowed Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.934 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.532 HG23 ' O ' ' A' ' 34' ' ' GLY . 4.9 pt -159.52 133.52 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.79 0.329 . . . . 0.0 111.038 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 1.5 m -96.76 149.06 22.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.943 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.446 HD12 ' HG2' ' A' ' 83' ' ' LYS . 1.8 pp -139.42 155.57 25.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.118 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -152.05 137.84 6.15 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.405 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -170.14 170.06 42.64 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.438 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.7 -124.37 5.08 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.499 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.693 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -175.34 -54.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.828 0.347 . . . . 0.0 111.197 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -93.93 -62.05 1.42 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 24.9 p90 -79.07 -24.44 43.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.998 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 1.8 m -146.66 74.65 12.38 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.937 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -68.3 -26.3 35.58 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.527 2.151 . . . . 0.0 112.313 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 45.2 t -62.34 133.9 55.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.567 ' HG ' HG21 ' A' ' 86' ' ' VAL . 1.6 mm? -97.65 161.92 13.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -150.87 164.25 36.73 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.055 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.495 HG22 ' N ' ' A' ' 50' ' ' VAL . 27.7 mt -97.1 160.03 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.975 179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.495 ' N ' HG22 ' A' ' 49' ' ' ILE . 20.3 t -110.11 -67.15 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.185 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -166.86 -178.05 4.1 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.976 -179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 53' ' ' PHE . 3.4 t -118.74 164.7 14.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.06 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.656 ' HB2' HG21 ' A' ' 56' ' ' THR . 33.7 m-85 -106.86 155.91 19.25 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.576 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -76.11 152.04 36.87 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.922 0.391 . . . . 0.0 111.081 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 m-80 61.11 28.59 18.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.357 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.656 HG21 ' HB2' ' A' ' 53' ' ' PHE . 70.4 p -111.96 155.05 43.9 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.719 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 56' ' ' THR . 25.3 Cg_endo -61.85 -30.26 83.93 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.406 2.071 . . . . 0.0 112.247 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -72.81 -38.78 67.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.211 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -79.41 -47.65 15.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.034 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 14.0 mt -58.1 -42.92 86.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.89 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -68.86 -30.47 69.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 65.12 86.52 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.509 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.731 HG21 ' CB ' ' A' ' 23' ' ' VAL . 6.0 m -154.59 -66.9 0.13 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.828 0.347 . . . . 0.0 110.934 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.6 m -96.36 144.72 9.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.182 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -174.96 -170.33 0.45 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.445 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.51 135.04 46.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.161 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 96.4 -37.71 3.34 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.487 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' O ' HD12 ' A' ' 49' ' ' ILE . 9.2 m-20 -60.03 111.13 1.38 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.796 0.331 . . . . 0.0 110.802 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -77.23 109.01 10.75 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.981 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' O ' HD11 ' A' ' 78' ' ' ILE . 16.9 tt -77.03 134.44 28.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.907 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.4 t -149.66 43.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.143 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.51 148.93 5.47 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.412 -0.899 . . . . 0.0 112.732 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.76 HG11 ' CD1' ' A' ' 90' ' ' ILE . 25.7 t -153.9 133.18 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.688 0.28 . . . . 0.0 110.92 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.481 HD22 HG12 ' A' ' 73' ' ' VAL . 16.2 p30 44.1 30.57 0.44 Allowed 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.431 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 78.61 36.12 30.49 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.466 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -135.37 149.33 49.66 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.869 0.366 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.2 m -79.84 128.28 33.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.901 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.572 HG21 HG23 ' A' ' 73' ' ' VAL . 2.6 pp -112.67 -23.21 4.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.487 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -52.92 -29.13 26.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.191 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.92 -23.86 29.03 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.65 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -77.18 160.97 28.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.889 0.376 . . . . 0.0 110.983 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.693 HG23 ' HB2' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -84.06 171.67 12.7 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.828 179.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.557 ' HD2' HG23 ' B' ' 123' ' ' VAL . 2.8 ttmt -58.69 -43.07 89.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.73 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 26.0 t -66.98 -33.02 60.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.916 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -67.42 -50.95 57.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.878 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.567 HG21 ' HG ' ' A' ' 47' ' ' LEU . 22.0 t -61.16 -46.19 97.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.196 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -56.63 -52.89 63.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.108 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.69 -33.25 74.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.75 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.892 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -59.55 -54.35 47.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.887 179.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.76 ' CD1' HG11 ' A' ' 73' ' ' VAL . 38.4 mm -58.08 -48.65 83.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.963 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.519 ' NE2' HG22 ' B' ' 125' ' ' ILE . 51.7 mt-30 -64.09 -25.83 68.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.881 179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -79.75 -39.38 31.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.961 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.892 HG23 ' O ' ' A' ' 89' ' ' MET . 15.2 t -58.88 142.21 14.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.051 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 10.5 mttp -123.59 159.97 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 75.63 -140.06 25.51 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.369 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -82.21 97.86 8.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.796 0.331 . . . . 0.0 110.831 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG21 ' HE2' ' A' ' 27' ' ' LYS . 23.0 t -79.9 147.34 6.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.136 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.504 ' C ' HD12 ' A' ' 99' ' ' ILE . 4.3 m -126.79 141.85 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.926 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 99' ' ' ILE . 4.3 mp -137.5 128.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.175 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -88.59 94.58 9.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.756 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -93.25 166.56 12.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -135.59 113.94 11.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.881 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -71.65 141.09 49.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.486 ' HG ' HG22 ' A' ' 18' ' ' THR . 2.5 mp . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.83 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.82 0.343 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 67.0 p -105.09 141.11 37.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.92 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.557 HG23 ' HD2' ' A' ' 83' ' ' LYS . 22.8 t -97.77 116.58 40.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.083 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.418 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -80.09 136.82 36.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.519 HG22 ' NE2' ' A' ' 91' ' ' GLN . 2.5 pp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.271 -0.871 . . . . 0.0 111.106 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 34.7 p . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.832 0.349 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 13.5 t -124.38 86.02 55.21 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.218 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.83 84.19 1.29 Allowed 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.561 2.174 . . . . 0.0 112.323 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -111.29 157.71 14.79 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.583 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -116.21 142.89 46.23 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.82 0.343 . . . . 0.0 110.797 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.633 HG21 HG21 ' A' ' 63' ' ' THR . 11.2 p -131.19 132.09 63.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.194 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 HG22 ' HB2' ' A' ' 96' ' ' GLU . 5.3 m -92.4 91.25 7.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.857 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.751 HD21 HG21 ' A' ' 63' ' ' THR . 8.6 mt -86.47 145.46 26.81 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -92.66 125.65 37.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.915 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.645 ' HZ3' HG23 ' A' ' 33' ' ' ILE . 3.7 mmtm -59.13 141.67 53.54 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.921 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -78.47 -168.83 1.47 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.965 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -68.85 -29.55 67.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.151 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.61 29.51 3.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.957 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 43.23 43.33 3.97 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.54 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' B' ' 125' ' ' ILE . 48.5 mt -144.6 100.54 3.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.048 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.645 HG23 ' HZ3' ' A' ' 27' ' ' LYS . 14.6 pt -55.61 -27.17 21.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.181 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.672 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 88.44 83.21 1.26 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.738 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.672 HG23 ' O ' ' A' ' 34' ' ' GLY . 1.1 pt -164.12 123.16 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 120.791 0.329 . . . . 0.0 110.961 179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.1 t -85.91 152.12 23.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.778 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.518 ' O ' HD12 ' A' ' 37' ' ' ILE . 2.8 pp -149.63 151.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.122 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.51 95.07 0.28 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.549 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA3' HD12 ' A' ' 47' ' ' LEU . . . -170.1 138.75 5.18 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.507 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.03 -63.57 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.526 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -162.64 -163.87 0.94 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.711 0.291 . . . . 0.0 111.071 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 64.37 59.77 0.98 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.997 0.427 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER 62.26 29.35 17.37 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.145 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 68.8 m -150.63 64.58 6.57 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 23.6 Cg_exo -64.05 -47.13 6.96 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.636 2.224 . . . . 0.0 112.088 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 17.4 m -62.2 169.63 2.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.965 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.485 HD22 HG11 ' A' ' 86' ' ' VAL . 6.2 mp -123.47 132.23 53.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.794 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -111.05 127.1 55.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.004 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 48.0 mt -76.64 137.45 22.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 51' ' ' GLN . 0.2 OUTLIER -102.05 -171.07 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.71 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.471 ' H ' HG12 ' A' ' 50' ' ' VAL . 1.8 pt20 -61.41 124.7 21.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.841 0.353 . . . . 0.0 111.07 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.529 HG13 ' O ' ' A' ' 34' ' ' GLY . 3.3 t -75.05 164.59 3.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.075 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' N ' HG12 ' A' ' 52' ' ' VAL . 15.8 m-85 -95.58 151.73 19.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.551 179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -72.94 158.62 35.13 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.204 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 47.7 m-80 64.59 21.92 12.53 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.537 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 63.4 p -102.5 148.62 35.74 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.677 179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.83 -28.75 86.92 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.483 2.122 . . . . 0.0 112.088 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -77.4 -31.71 54.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.935 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -87.51 -30.23 20.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.028 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.55 -33.99 53.93 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -75.51 -41.03 56.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.803 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.47 88.43 0.49 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.537 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.751 HG21 HD21 ' A' ' 25' ' ' LEU . 5.1 t -157.47 -47.84 0.07 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.825 0.345 . . . . 0.0 110.898 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.63 HG22 HG23 ' A' ' 63' ' ' THR . 11.2 m -124.84 136.52 60.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.223 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -165.69 -176.95 4.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.131 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' HB2' ' HA ' ' A' ' 51' ' ' GLN . . . -57.0 90.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.101 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.51 -30.36 0.21 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.448 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -91.53 176.93 6.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.848 0.356 . . . . 0.0 110.886 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -129.56 106.85 9.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.922 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 13.7 tt -70.13 147.19 11.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.052 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.584 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.0 t -168.01 33.37 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 179.35 145.34 6.22 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.47 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.837 HG21 ' CD1' ' A' ' 90' ' ' ILE . 9.1 p -154.04 122.89 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.817 0.341 . . . . 0.0 111.024 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 59.22 36.91 23.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.876 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 74.02 10.63 81.14 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.833 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.02 143.47 36.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.843 0.354 . . . . 0.0 110.886 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.3 m -83.87 115.51 22.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.827 179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.611 ' O ' HD12 ' A' ' 78' ' ' ILE . 2.4 pp -92.87 14.37 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.575 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.7 mttp -71.58 -30.25 65.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.816 0.341 . . . . 0.0 110.948 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.28 47.04 1.14 Allowed Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.562 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.0 mttt -142.5 151.91 42.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 0.7 OUTLIER -82.16 171.69 14.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.97 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.568 ' HD2' HG23 ' B' ' 123' ' ' VAL . 0.0 OUTLIER -57.43 -51.18 70.47 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.954 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.7 m -63.85 -30.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.049 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -69.62 -51.15 37.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.893 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' THR . 24.4 t -60.21 -47.02 93.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.019 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.618 ' CB ' HG11 ' B' ' 123' ' ' VAL . . . -59.08 -40.39 85.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.117 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.66 -37.69 87.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.824 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.477 ' HE2' HG11 ' A' ' 73' ' ' VAL . 2.9 ttp -62.2 -52.05 65.32 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.829 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.837 ' CD1' HG21 ' A' ' 73' ' ' VAL . 25.4 mm -63.86 -29.93 48.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.207 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -77.32 -25.15 50.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.893 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 38.6 mm-40 -82.73 -55.78 4.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.072 -179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.453 HG13 HG11 ' A' ' 97' ' ' VAL . 13.3 p -58.64 138.51 19.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.18 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 mttm -121.36 -173.75 2.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.765 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 59.72 -168.6 7.6 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.558 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.554 ' HB2' HG22 ' A' ' 24' ' ' THR . 5.9 pt-20 -58.84 107.03 0.47 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.822 0.344 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.61 HG11 ' HE2' ' A' ' 27' ' ' LYS . 22.2 m -107.01 141.91 21.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.25 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.428 ' C ' HD12 ' A' ' 99' ' ' ILE . 1.6 m -104.84 141.63 36.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.921 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.588 HD13 HD12 ' A' ' 25' ' ' LEU . 4.7 mp -134.04 131.87 55.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -90.93 104.95 17.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.926 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -111.5 150.38 30.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.879 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -118.02 126.13 51.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -88.33 127.99 35.49 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.834 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.159 -179.907 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.748 0.308 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 20.9 m -104.05 164.39 11.74 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.618 HG11 ' CB ' ' A' ' 87' ' ' ALA . 27.6 t -109.18 127.44 65.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.445 ' HG3' ' CE1' ' A' ' 53' ' ' PHE . 0.0 OUTLIER -96.7 118.68 33.68 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.879 179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.794 HD13 HG21 ' A' ' 90' ' ' ILE . 2.7 pp . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.208 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.511 HG22 ' HB3' ' A' ' 102' ' ' ASN . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.152 0 CA-C-O 120.728 0.299 . . . . 0.0 110.927 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HA ' ' HD2' ' A' ' 20' ' ' PRO . 17.0 t -89.78 106.75 15.26 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.017 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 19' ' ' VAL . 32.8 Cg_endo -64.25 107.01 0.75 Allowed 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.325 2.017 . . . . 0.0 112.396 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.31 121.05 2.73 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.405 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.2 ptpp? -103.79 139.24 39.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.856 0.36 . . . . 0.0 110.963 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.755 HG21 HG21 ' A' ' 63' ' ' THR . 10.3 p -134.71 131.55 53.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.061 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.541 HG22 ' HB2' ' A' ' 96' ' ' GLU . 1.8 m -91.05 98.26 11.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.824 HD12 HD13 ' A' ' 99' ' ' ILE . 1.0 OUTLIER -106.72 136.51 46.41 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.819 179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . 0.688 ' O ' HG22 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -82.55 168.26 17.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.88 179.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.806 ' HE2' HG21 ' A' ' 97' ' ' VAL . 4.0 mttm -91.7 140.2 29.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -64.73 -172.98 0.09 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.3 -28.38 69.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.254 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.495 ' HG3' HD12 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -96.89 24.79 5.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.15 -179.893 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 9.5 t30 54.69 36.04 25.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.153 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.495 HD12 ' HG3' ' A' ' 30' ' ' GLN . 85.3 mt -139.59 108.11 5.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.901 -179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 35' ' ' ILE . 13.9 pt -54.28 -27.2 16.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.202 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.665 ' O ' HG23 ' A' ' 35' ' ' ILE . . . 84.29 81.1 1.04 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.645 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.853 HD11 HD11 ' A' ' 33' ' ' ILE . 1.1 pt -164.13 117.53 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.759 0.314 . . . . 0.0 111.032 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 37.7 t -83.79 140.07 32.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.762 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . 0.481 HD12 ' C ' ' A' ' 37' ' ' ILE . 2.6 pp -135.69 173.6 13.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.267 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -153.16 131.78 3.43 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.368 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . -146.23 170.11 27.41 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.581 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.99 -38.4 0.29 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.652 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.596 ' HB3' HG23 ' A' ' 82' ' ' THR . . . 65.54 160.12 0.12 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.094 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 70.04 -64.97 0.33 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.012 179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 39.6 p90 -107.29 -30.73 8.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.107 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.401 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 40.9 m -137.17 65.77 51.55 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.11 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.401 ' HD3' ' N ' ' A' ' 44' ' ' CYS . 16.6 Cg_exo -67.43 -28.27 39.07 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.704 2.27 . . . . 0.0 112.189 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 4.5 t -56.91 97.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.147 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.904 HD21 HG21 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -75.97 169.98 17.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.675 179.775 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -160.95 144.23 13.07 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.141 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 50' ' ' VAL . 20.4 mt -73.56 160.46 5.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.733 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.568 ' O ' ' HB2' ' A' ' 66' ' ' ALA . 21.5 t -117.25 -68.17 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.67 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -160.85 147.7 15.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.887 0.375 . . . . 0.0 111.299 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.523 HG13 ' O ' ' A' ' 34' ' ' GLY . 1.6 t -98.55 159.55 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.884 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.478 ' O ' HG23 ' A' ' 56' ' ' THR . 22.1 m-85 -109.14 144.44 37.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.693 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.13 153.98 28.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.17 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.0 m120 70.87 17.04 6.47 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.67 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.478 HG23 ' O ' ' A' ' 53' ' ' PHE . 33.5 p -108.09 150.81 40.9 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 120.61 0.243 . . . . 0.0 110.623 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_endo -57.96 -29.77 87.67 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.432 2.088 . . . . 0.0 112.157 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -76.51 -34.4 58.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.148 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.83 -26.34 24.1 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.301 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 24.3 mt -77.11 -41.33 42.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.808 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -72.59 -50.23 26.84 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.937 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.88 67.65 1.14 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.541 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.755 HG21 HG21 ' A' ' 23' ' ' VAL . 0.2 OUTLIER -136.2 -67.83 0.51 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.891 0.377 . . . . 0.0 110.923 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.5 m -96.58 135.05 31.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.036 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.442 ' HB2' HG21 ' A' ' 52' ' ' VAL . . . -175.65 -173.48 0.62 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.137 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.568 ' HB2' ' O ' ' A' ' 50' ' ' VAL . . . -54.48 96.21 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.57 -32.71 1.21 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.353 179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -85.4 152.04 23.54 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.805 0.336 . . . . 0.0 110.848 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -109.55 109.41 20.19 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.582 ' O ' HD11 ' A' ' 78' ' ' ILE . 19.6 tt -69.97 124.43 25.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.513 ' HA ' HD11 ' A' ' 78' ' ' ILE . 10.1 t -142.9 33.76 1.38 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.948 -179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 175.11 169.39 36.9 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.774 -0.726 . . . . 0.0 112.581 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.63 HG21 HD13 ' A' ' 90' ' ' ILE . 7.3 p -167.04 113.46 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.846 0.355 . . . . 0.0 111.069 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 2.9 m120 56.83 26.43 11.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.074 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.56 -27.9 18.26 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.537 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.86 152.81 44.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.745 0.307 . . . . 0.0 110.895 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 1.5 m -98.25 118.9 35.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.582 HD11 ' O ' ' A' ' 70' ' ' ILE . 2.5 pp -92.34 13.48 2.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.481 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -67.63 -27.6 67.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.769 0.318 . . . . 0.0 111.022 -179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -113.11 49.96 0.81 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.586 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.2 mttt -140.38 162.04 36.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.845 0.355 . . . . 0.0 110.931 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.774 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -99.5 176.95 5.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.853 179.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 2.9 ttpm? -64.83 -34.25 77.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.969 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.481 HG13 ' N ' ' A' ' 85' ' ' GLU . 11.7 p -74.25 -44.81 48.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.853 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.481 ' N ' HG13 ' A' ' 84' ' ' VAL . 50.8 mm-40 -63.74 -48.97 74.88 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.799 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.904 HG21 HD21 ' A' ' 47' ' ' LEU . 17.4 m -59.81 -46.65 93.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.15 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.466 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -58.51 -36.17 73.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.842 0.354 . . . . 0.0 110.998 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.1 mtpt -75.58 -38.52 59.08 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.85 ' O ' HG23 ' A' ' 93' ' ' VAL . 4.7 ptm -60.09 -41.34 92.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.967 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.829 HG21 HD13 ' B' ' 125' ' ' ILE . 38.4 mm -72.28 -47.86 51.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.767 179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.42 ' HG3' HG22 ' B' ' 125' ' ' ILE . 8.7 mt-30 -59.37 -24.74 63.66 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.72 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -80.08 -45.14 18.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.877 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.85 HG23 ' O ' ' A' ' 89' ' ' MET . 25.3 t -57.07 144.57 9.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.21 168.12 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 68.52 -136.84 30.13 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.446 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.541 ' HB2' HG22 ' A' ' 24' ' ' THR . 0.2 OUTLIER -78.98 99.95 7.07 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.773 0.32 . . . . 0.0 110.877 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.806 HG21 ' HE2' ' A' ' 27' ' ' LYS . 36.2 t -92.35 124.91 44.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.045 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.711 ' C ' HD12 ' A' ' 99' ' ' ILE . 2.2 m -97.72 144.07 27.72 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.072 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.824 HD13 HD12 ' A' ' 25' ' ' LEU . 3.6 mp -137.14 123.44 28.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' HIS . . . . . . . . . . . . . 41.5 m-70 -88.64 100.54 13.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.848 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' TYR . . . . . 0.41 ' CE2' HG22 ' A' ' 63' ' ' THR . 39.2 p90 -100.06 147.26 25.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.907 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.511 ' HB3' HG22 ' A' ' 18' ' ' THR . 57.6 m-20 -110.75 121.37 45.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.837 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 46.1 mttt -73.84 117.34 15.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.829 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.128 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 121' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.741 0.305 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 122' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.67 155.94 38.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.956 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 123' ' ' VAL . . . . . 0.457 HG11 ' CB ' ' A' ' 87' ' ' ALA . 21.1 t -129.66 117.58 42.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.091 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 124' ' ' LYS . . . . . 0.428 ' NZ ' HD13 ' A' ' 32' ' ' LEU . 0.0 OUTLIER -88.07 117.28 26.85 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.863 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 125' ' ' ILE . . . . . 0.829 HD13 HG21 ' A' ' 90' ' ' ILE . 2.6 pp . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.28 -0.867 . . . . 0.0 111.226 179.914 . . . . . . . . 1 1 . 1 stop_ save_